TIDMACRL
RNS Number : 5118K
Accrol Group Holdings PLC
10 July 2017
This announcement contains inside information
10 July 2017
Accrol Group Holdings plc
Preliminary results for the twelve months ended 30 April
2017
Accrol Group Holdings plc, the AIM listed leading independent
tissue converter, is pleased to announce its preliminary results
for the twelve months to 30 April 2017.
Financial Highlights
-- Revenue increased 14.2% to GBP135.1m (FY16: GBP118.2m)
-- Gross Profit increased 9.3% to GBP37.7m (FY16: GBP34.5m)
-- Adjusted gross margin(1) was 27.9% (FY16: 28.1%) supported by
favourable parent reel pricing and significant currency hedging
-- Adjusted EBITDA(1) increased 6.8% to GBP16.1m (FY16: GBP15.0m)
-- Adjusted profit after tax(1) increased 57.3% to GBP11.0m (FY16: GBP7.0m)
-- Profit after tax increased 29.3% to GBP7.4m (FY16: GBP5.7m)
-- Continued strong cash generation in a period which included a
GBP3.6m repayment of loan note interest
-- Net debt reduced by GBP41.7m to GBP19.0m (Net debt / Adjusted
EBITDA reduced from 4.0x to 1.2x)
-- Basic EPS of 9p and adjusted EPS of 12p
-- Final dividend proposed of 4p per ordinary share giving a
total of 6p per ordinary share for the full year
Operational Highlights
-- Successful maiden full year as a publicly listed company, with a solid trading performance
-- New contract wins have seen market share grow to over 50% of the Discount Sector
-- Good progress made in building a platform for future growth
-- Key new hires to operations and management functions
-- Opened new 168,000 sq. ft. manufacturing facility at Leyland,
Lancashire, with two tissue converting lines commissioned and a
third line expected in FY18
-- Supply Chain Optimisation plan implemented to improve and
simplify warehousing and logistics through a 368,000 sq ft. central
warehouse at Skelmersdale and managed by NFT Distribution
Steve Crossley, Chief Executive Officer of Accrol,
commented:
"This has been a year of positive change for Accrol as we have
transitioned to life as an AIM listed company. We have won new
contracts and increased our share of the Discount Sector to over
50%."
"We continue to build a platform for future growth, having made
a significant investment in our new manufacturing facility at
Leyland to create extra capacity. A new finished goods warehouse in
Skelmersdale, announced in May 2017, will provide central storage
and distribution facilities for our customers, improving our supply
chain efficiency and enabling us to build on our market
position."
"Increasing input costs, driven by exchange rates, are impacting
most product categories in UK retail and like all UK manufacturers,
we continue to seek inflation recovery. There are positive signs,
with some retailers increasing consumer price points, although it
is slower than we expected. We believe that as price increases come
through fully in the market, this will continue to drive shoppers
to seek good value in the Discount and Multiple own-label
sectors."
Note 1: Non-GAAP measures are reconciled in note 25
There will be an analyst presentation to discuss the results at
9am on 10(th) July 2017 at the offices of Camarco. Analysts
interested in attending should contact Kimberley Taylor on +44 203
757 4999.
The Company's annual report for the year ended 30 April 2017
(including notice of the annual general meeting to be held at
Accrol's Head Office in Blackburn on 6(th) October 2017 at 2pm)
(the "Annual Report") will shortly be available for downloading
from the Company's web site at
http://www.accrol.co.uk/investor-relations/.
For further information
please contact:
Zeus Capital Limited (Nominated
Adviser & Joint Broker)
Dan Bate / Jonathan Sharp Tel: +44 (0) 161 831
1512
Dominic King / Mike Seabrook Tel: +44 (0) 20 3829
/ John Goold 5000
Liberum Capital Limited
(Joint Broker)
Clayton Bush / Chris Clarke/ Tel: +44 (0) 20 3100
Lucy Sharma / Dominik Götzenberger 2222
Camarco (Media enquiries)
Jennifer Renwick / Kimberley Tel: +44 (0) 203 757
Taylor 4994
Notes to Editors
Accrol manufactures toilet rolls, kitchen rolls and facial
tissues as well as other tissue products. The Company operates out
of c. 900,000 sq. ft. of manufacturing, storage and distribution
facilities across Lancashire. Accrol currently manufactures
approximately 18 million units per week and supplies some of the
UK's largest retailers, providing both Accrol branded and Private
Label products (being goods produced under a customer's own brand
or under a non-branded or less well-known brand name ("private
label")).
The Group's competitive advantage lies in its market
positioning, operational process and flexibility. Key components of
the business model are:
Production process - The Directors believe the Group obtains a
competitive advantage through its model of acquiring and converting
the large tissue reels that are Accrol's raw materials ("Parent
Reels") as opposed to manufacturing Parent Reels from pulp and
recycled fibre and subsequently converting. This requires a lower
fixed overhead and provides flexibility in Parent Reel sourcing
which allows the Group to take advantage of favourable pricing
opportunities and production technology advancements, especially in
a market of excess supply.
Technology and converting lines - Accrol has invested c.GBP18.2
million over the last three years with c. GBP4.0 million committed
to a new machine for delivery in March 2018. The Group currently
has 17 converting lines in operation providing capacity of
approximately 143,000 tonnes per annum. The Group's operating
machinery allows conversion of a wide variety of tissue grades,
adding flexibility to the Parent Reel sourcing process and allowing
manufacture of a wide range of product types.
Manufacturing private label products - The majority of Accrol's
products (84 per cent. of revenues in the year ended 30 April 2017)
are private label and whilst the Group also develops and supplies
branded products, the ability to supply customers with goods under
its own brand has allowed penetration into retailers operating in
the discount market ("Discounters") and the UK's largest retailers
("Multiples"). Accrol can launch a new private label product within
six weeks of instruction from a retailer.
Production flexibility - Accrol is able to manufacture toilet
rolls, kitchen rolls, facial tissue and certain products used
outside a consumer's home ("Away from Home" or "AFH"), providing a
"one-stop shop" solution for customers in the tissue market. The
ability to produce these goods and supply Multiples, Discounters,
local retailers and wholesalers ("Independents") and the AFH market
is a competitive advantage and the Directors do not believe any
competitors can offer the same flexibility across all of these
market channels.
Macro-economic impact on raw material prices - There is
currently a global over-supply of both pulp and Parent Reels, with
additional capacity forecast to be brought on stream through to
2019. As such, Parent Reel prices are currently relatively low and
are expected to remain so for the foreseeable future. Low Parent
Reel prices allow Accrol to manufacture at a lower cost, enhancing
margin and providing pricing flexibility to win new orders.
Overcapacity drives increased flexibility of supply and provides
Accrol with a choice of pricing and technology when sourcing Parent
Reels.
Market positioning - Having won a number of contracts with
Discounters in recent years and benefitting from the organic growth
within this market, the Directors believe Accrol is well positioned
to take advantage of the growth in the discount market and
Multiples' increased focus on private label products.
Chairman's review
Our maiden year results show a further year of growth
Overview of the year
I am delighted to report that FY17 was another successful year
for the Group. Our revenue grew to GBP135.1million, increasing 14%
compared to FY16 and in line with market expectations.
Adjusted EBITDA increased to GBP16.1million, up 7%, and Adjusted
Profit Before Tax increased GBP4.8 million to GBP13.0 million, up
58%. Profit After Tax has risen to GBP7.4 million, up 29%.
With Grocery inflation rising during the year, consumer footfall
in the Discount Sector showed no signs of slowing down as shoppers
continued to look for ways of offsetting rising household prices
and switching to lower cost alternatives. As a result of new
contract wins starting in late 2016, our value of market share in
the Discount Sector grew to over 50% (FY16: c. 35%), firmly
endorsing Accrol as the soft tissue supplier of choice for the
sector.
The year was not without its challenges. In anticipation of
Sterling weakness and volatility following the UK's decision to
leave the European Union, we moved to protect ourselves from
adverse exchange rates fluctuations by significantly hedging our
exposure to help mitigate raw material cost price increases.
However, we have continued to look ahead, positioning ourselves for
growth, investing in both our facilities and our team to help us
capitalise on the market opportunity.
During the year, we opened our new production facility at
Leyland, Lancashire, which gives us the opportunity to install a
total of six tissue converting lines and the potential to generate
revenues in excess of GBP100 million from the site, and GBP250
million in aggregate. We currently have two lines installed and
recently announced the addition of a third line which will be
installed towards the end of 2018, as we seek to extend our reach
into the Major Multiples.
We also embarked on an ambitious plan to reorganise our
warehousing and logistics operations, creating a centralised
finished goods hub next to the M58 in Skelmersdale, Lancashire.
This will enable us to better service our customers and prepare for
future growth.
Accrol's founders, the Hussain family, have now fully exited the
business in line with the strategy we set out at IPO, and we have
made a number of new senior management hires across the business. I
would like to thank the Hussain family for a smooth and successful
transition to new management.
Strategy and outlook
The continued over supply of Parent Reels shows no sign of
abating and as of January 2017, globally a further 111 tissue mills
were on order or in their final stages, keeping pricing competitive
and supporting our strategy to procure parent reels versus own
manufacture. We will continue to source reels from around the
globe, taking advantage of new technology and spare capacity.
The majority of Private Label retail shelf prices for soft
tissue are still at pre-EU referendum levels. There are positive
signs that this is changing, albeit slower than expected, and we
expect the industry as a whole to pass on the effects of the weaker
pound as currency contracts unwind.
Key to our expansion will be to strengthen our relationships in
the growing Discount Sector, the continued consumer shift towards
private label tissue products and winning new business in the
Multiple Retail Sector. Our recent investment in new production
capacity, logistics and warehousing facilities will allow us to
build on our strong market position.
Dividend policy
The Board remains committed to a progressive dividend policy.
The interim dividend of 2p per share was paid in February 2017. The
Board has proposed a final dividend of 4p per share, which together
with the interim dividend represents a 6% yield at the IPO listing
price.
The final dividend is subject to the approval of the Company's
shareholders and will be paid on 11 October 2017 to shareholders on
the register on 22 September 2017. The Company's ordinary shares
will become ex-dividend on 21 September 2017.
Peter Cheung
Executive Chairman
10 July 2017
Chief Executive Officer's review
Market overview
FY17 has been a year of delivery and positioning for future
growth for Accrol, with the UK tissue market currently worth GBP2.2
billion at retail selling price.
Although there has been a small decline due to promotional
activity in the value of consumer sales through Multiples and
Discounters, down 1.5% to GBP1.5 billion, the Discount Sector
continues to demonstrate the most significant growth at over 10%
per annum. Brands continue to be slowly eroded with Own-Label
within the Major Multiples reaching 47% of the total market by
March 2017. Inflation, driven by a fall in the value of Sterling
following the EU referendum, first appeared in the tissue category
in early 2017 and is expected to accelerate as the year
continues.
In anticipation of exchange rate volatility immediately ahead
of, and following, the EU Referendum, Accrol entered into a
significant number of forward contracts to hedge its currency
exposure. This, along with favourable parent reel pricing dynamics,
enabled Accrol to minimise the impact of foreign exchange rate
volatility on its financial performance through FY17. As exchange
rates continue to be weak in favour of the US Dollar, tissue
manufacturers and convertors are facing rising raw material prices
as pulp is traded in US Dollars on global markets. Accrol is well
advanced in conversations with customers regarding inflation
recovery but they are challenging and will take time to
conclude.
Strategy
Throughout the year we have focused on our long-term strategy of
increasing our share of the Discount Sector as increasing inflation
encourages UK shoppers to search out quality and value and further
accelerates the growth of the Discount Sector. Evidence of this can
already be seen with Aldi and Lidl both recently reporting market
share growth of almost 20%. Increasing product prices will also see
further moves in sales from brands into Own-Label within the Major
Multiples as they all seek to re-set their ranges and shopper
offering. Our aim of gaining further Own-Label business with the
Major Multiples therefore also remains a key strategic
objective.
Our sourcing strategy of purchasing parent reels globally from
partner paper mills will continue to be a key point of difference.
Leveraging strong commercial terms, flexibility on sourcing new
technologies and better use of cash remain the key advantages of
this sourcing strategy as opposed to a vertically integrated model.
There is still significant over capacity in the world pulp and
tissue markets as new paper mills continue to come online, which
appears set to continue through to 2019.
Contracts
We won a number of new contracts in FY17, the most significant
being the launch of Lidl's Floralys range in November 2016. The
account has continued to trade above the original expected levels
of circa GBP10 million per annum.
Relationships with key customers remain positive and our
investment for future growth by increasing capacity and improving
our supply chain has been well-received. Our relationship with
Booker, Accrol's largest customer, continues to be strong and we
have recently signed a new supply agreement.
Conversations with the Major Multiples continued throughout the
year and all outlined the need for an increase in Accrol's
manufacturing capacity in order to move major tranches of volume,
supporting the importance of our continued investment in the
business.
Increased input costs driven by exchange rates have prompted
inflation recovery conversations and, subsequently, more tender
processes across the industry.
Investment
Significant progress has been made on building a platform for
future growth during the year. A suitable 168,000 sq. ft. site was
quickly identified and secured at Leyland, Lancashire. From moving
into the building in late October 2016, the premises were modified
for manufacturing use with the 2 converting lines installed from
January 2017 onwards. Commissioning on the first line was completed
in April 2017 and on the second line in June 2017. Ramp up of
volume has continued with the addition of new shift patterns and
will continue into FY18. We recently announced the purchase of a
further tissue conversion line which will take the total business
capacity to 158,000 tonnes for FY18 or circa GBP200 million per
annum sales. The Leyland site has space for a further three
conversion lines in addition to the three lines that will be in
place.
In addition to laying down new capacity, an investment programme
commenced in the year on the existing Blackburn sites to improve
operational efficiency, and hence overall capacity. This includes
staff training and a new rotating shift pattern that is more
employee friendly.
The final part of the investment for growth strategy in FY17 was
the implementation of a Supply Chain Optimisation plan to improve
and simplify warehousing and logistics, creating additional
capacity for growth. A more efficient single 'big shed' solution
was adopted and a site quickly identified on the M58 at
Skelmersdale in Lancashire. This 368,000 sq. ft. warehouse is newly
refurbished and will house finished goods and provide central
distribution facilities to all UK customers. Warehouse management
and national logistics will be contracted out to a third-party
provider, NFT, enabling the Accrol management team to focus on its
core competencies of sourcing and manufacturing.
People
Following our IPO in June 2016, a new PLC Board was put in place
and a review of our organisational structure was undertaken. Key
gaps were identified and have subsequently been filled with highly
experienced industry experts. The new team helped transition the
Hussain family out of the business by October 2016 as agreed in a
collaborative and controlled manner.
People remain our most important asset and further investment
continues to be made into their working environment through a focus
on equipment and health and safety, into their welfare through more
employee friendly rotating shift patterns, and into respecting
their views and opinions through employee engagement.
Market opportunities / outlook
The Directors believe that Accrol's strategy remains relevant
for the marketplace and that there continue to be opportunities for
further growth. The move toward Discounters and Own-Label will be
accelerated as shoppers try to reduce the inevitable impact of
inflation without compromising on quality. Despite the exchange
rate driven inflationary pressures and the slower than expected
consumer price increases which the whole industry faces into, the
Directors remain confident that when price increases do come
though, our sourcing policy and investment in capacity, supply
chain efficiency and people has positioned Accrol to take advantage
of the marketplace dynamics.
Steve Crossley
Chief Executive Officer
10 July 2017
Chief Financial Officer's review
Continued strong sales, profit and cash growth
Sales of Private Label products into Discounters and Multiples
delivered year on year a 14% growth in revenues and a 58% growth in
adjusted profit before tax. Net debt reduced by 69% to
GBP19.0m.
Key performance indicators
2017 2016 Change
GBP'000 GBP'000
---------------------------- ----------- ----------- -------
Revenue 135,053 118,219 +14.2%
Adjusted gross margin
(1) 27.9% 28.1%
Adjusted EBITDA (2) 16,061 15,038 +6.8%
Finance costs 1,129 4,941 -77.2%
Adjusted profit before
tax(3) 13,022 8,266 +57.5%
Adjusted profit after
tax(4) 10,999 6,992 +57.3%
Free cash flow(5) 7,384 4,696 +57.2%
Net debt 18,988 60,656 -68.7%
Net debt / adjusted EBITDA 1.18 times 4.03 times
EPS - basic GBP0.09 GBP576.26
-- Revenues increased by 14.2% to GBP135.1 million
-- Gross profit increased 9.3% to GBP37.7m (FY16: GBP34.5m)
-- Adjusted gross margin was 27.9% (FY16: 28.1%) supported by
favourable parent reel pricing and significant currency hedging
-- Adjusted EBITDA increased by 6.8% year on year to GBP16.1m (FY16: GBP15.0m)
-- Adjusted profit before tax increased 57.5% year on year to GBP13.0m
-- Adjusted profit after tax increased 57.3% year on year to GBP11.0m
-- Continued strong cash generation which included a GBP3.6m
repayment of loan note interest in the current year
-- Net debt reduced GBP41.7m year on year to GBP19.0m with net
debt to adjusted EBITDA reducing from 4.0 times to 1.2 times
-- Basic EPS of 9p (FY16: 57,626p)
-- Final dividend proposed of 4p per ordinary share giving a
total of 6p per ordinary share for the full year
Income statement
Statutory
-----------------------------
2017 2016
GBP'000 GBP'000 Change
Revenue 135,053 118,219 +14%
Cost of sales before gain / (loss)
on derivative financial instruments (97,374) (84,996)
Gain / (loss) on derivative instruments - 1,266
----------------------------------------- --------- --------- -------
Cost of sales (97,374) (83,730)
----------------------------------------- --------- --------- -------
Gross profit 37,679 34,489 +9%
Administration expenses (15,698) (13,138)
Distribution costs (11,453) (9,431)
----------------------------------------- --------- --------- -------
Operating profit 10,528 11,920 (12%)
Analysed as:
- Adjusted EBITDA (2) 16,061 15,038 +7%
- Depreciation (1,910) (1,831)
- Amortisation (2,042) (2,060)
- Gain / (loss) on derivative
financial instruments - 1,266
- Exceptional items (1,581) (493)
----------------------------------------- --------- --------- -------
Operating profit 10,528 11,920 (12%)
----------------------------------------- --------- --------- -------
Finance costs (1,129) (4,941)
----------------------------------------- --------- --------- -------
Profit before tax 9,399 6,979 +35%
Tax charge (2,023) (1,274)
----------------------------------------- --------- --------- -------
Profit for the year attributable
to equity shareholders 7,376 5,705 +29%
----------------------------------------- --------- --------- -------
Gross margin % 27.9% 29.2%
Adjusted gross margin % 27.9% 28.1%
Note 1: Adjusted gross margin, which is defined as gross profit
excluding the (loss) / gain on derivative financial instruments is
a non-GAAP metric used by management and is not an IFRS
disclosure.
Note 2: Adjusted EBITDA, which is defined as profit before
finance costs, tax, depreciation, amortisation, (loss) / gain on
derivative financial instruments and exceptional items, is a
non-GAAP metric used by management and is not an IFRS
disclosure.
Note 3: Adjusted profit before tax, which is defined as profit
before tax, amortisation, (loss) / gain on derivative financial
instruments and exceptional items, is a non-GAAP metric used by
management and is not an IFRS disclosure.
Note 4: Adjusted profit after tax, which is defined as profit
after tax, amortisation, (loss) / gain on derivative financial
instruments and exceptional items, is a non-GAAP metric used by
management and is not an IFRS disclosure
Note 5: Free cash flow, which is net cash flow from operating
activities is a GAAP measure used by management.
Revenues
FY17 FY16 VAR
% % %
Discounter 74% 69% 5%
Multiple 8% 9% (1%)
Other 18% 22% (4%)
100% 100% 0%
Revenues grew by 14.2% or GBP16.8 million year on year with the
majority of the growth coming from the Discounters. The Discount
segment of the UK tissue market has increased from 14% to 16%,
taking share from the Multiples. In terms of products, toilet
tissue revenues showed the highest year on year growth of 27.3% or
GBP14.6m. As a proportion of revenue, toilet tissue has increased
from 44% in the prior year to 49% in the current year.
Gross margin
Adjusted gross margin decreased marginally by 0.2% from 28.1%
for the year ended 30 April 2016 to 27.9% for the year ended 30
April 2017. Adjusted gross margin excludes the impact of unrealised
gains and losses on outstanding forward foreign currency contracts
valued at the Balance Sheet date. The decrease of 0.2% is mainly
due to:
-- In order to reduce the impact of the adverse movements in
both the US$ and Euro exchange rates, we entered into a significant
volume of forward currency contracts ahead of, and following, the
EU referendum, selling Sterling and purchasing both US$ and Euros.
This coupled with a favourable parent reel pricing delivered a 0.3%
improvement in adjusted gross margin.
-- We have continued to invest in production head count to
support the sales growth at a cost of 0.5% of adjusted gross
margin.
Administration costs
Administrative costs have increased year on year by GBP2.6m to
GBP15.6m, mainly due to a GBP1.1m increase in exceptional costs,
GBP0.6m due to increased wage costs as we continue to invest in
people to support the sales growth, GBP0.3m due to plc related
running costs and GBP0.6m due to insurance, depreciation and
utilities.
Exceptional costs of GBP1.6m in the current year relate to AIM
flotation costs of GBP0.2m (balance of GBP1.6m is included in the
share premium account), consulting costs of GBP0.6m, an early
settlement fee on finance leases of GBP0.4m and the write-off of
previous deal related costs attached to the previous debt structure
of GBP0.4m.
Distribution costs
Distribution costs as a percentage of revenue has increased year
on year by 0.5% to 8.5%. The increase is mainly due to destination
mix change with an increased number of southern depots coupled with
an increased usage of packaging materials.
Finance costs
Finance costs have decreased significantly year on year by
GBP3.8m to GBP1.1m mainly due to the restructuring of the debt at
listing on AIM in June 2016. The 10% fixed rate secured manager
loan notes, the 10% fixed rate secured investor loan notes and the
majority of the finance leases were repaid at listing. A new
Revolving Credit Facility of GBP18.0m was put in place at IPO with
a drawdown at IPO of GBP13.0m.
Taxation
The effective tax rate for the year was 21.5% which is higher
than both the standard rate of UK taxation and the prior year
(18.3%), primarily as a result of non-deductible expenses, which
largely relate to professional and to an element of interest
charges on loan notes which are not deductible for tax purposes.
The change in the statutory tax rate to 19.92% (2016: 20%) is due
to the reduction in the main rate of corporation tax to 20% from 1
April 2016 to 19% from 1 April 2017.
Balance sheet
Property, plant and equipment
In the previous financial period, we acquired two further
converting lines at a cost of GBP3.2m. In the current year, we have
installed both of these machines in our new production facility at
Leyland. Start-up costs of GBP3.4m are included in assets under
construction with deprecation of the two lines and the start-up
costs starting from May 2017.
Intangibles
Intangibles comprise mainly of goodwill and customer
relationships. Under IFRS, goodwill is not amortised but is subject
to an impairment review on at least an annual basis. Consequently,
during the year, the directors performed a review, which involved
making assumptions about the future performance of the business.
After carefully considering various scenarios that could occur and
after looking at sensitivities on these scenarios, the directors
concluded that no impairment was required. Customer relationships
have been recognised at fair value and are amortised over 10
years.
Working capital
Actual
------------------------
2017 2016 Var
GBP'm GBP'm GBP'm
Inventories 14.4 9.4 5.0
Trade and other receivables 24.7 21.3 3.4
Trade and other payables (18.8) (15.5) (3.3)
20.3 15.2 5.1
Raw material stocks have increased by GBP2.1m with the majority
of the increase supporting the sales growth, with a smaller element
due to us taking spot deals to take advantage of lower parent reel
pricing. Finished goods stocks have increased by GBP2.9m year on
year, with last year significantly lower than expected due to
higher sales demand around year-end. Finished goods stock levels at
30 April 2017 are of an appropriate level to ensure we provide good
service to our customers.
Trade receivables have increased by GBP3.4m in line with the
sales growth, showing our continued tight control of cash
collection.
Trade payables have increased GBP3.3m as we are choosing to take
advantage of favourable credit terms on Parent Reels.
Borrowings and cashflow
Actual
----------------------
2017 2016 Var
GBP'm GBP'm GBP'm
Bank loan facility 12.8 3.7 (9.1)
Finance leases 0.5 10.9 10.4
Shareholder loans - 41.1 41.1
Factoring facility 9.5 7.5 (2.0)
------ ------ ------
Borrowings 22.8 63.2 40.4
Cash and cash equivalents (3.8) (2.5) 1.3
------ ------ ------
Net debt 19.0 60.7 41.7
As part of the AIM flotation process, shareholder loan notes,
bank loan facility and the majority of finance leases were repaid.
A new Revolving Credit Facility of GBP18.0m was put in place with a
day 1 draw down of GBP13.0m. The opening day net debt position
following flotation was GBP23.1m with the above position
representing a reduction of GBP4.1m to 1.18 times the FY17 adjusted
EBITDA.
Net cash flows from operating activities increased GBP2.7m or
57.2% to GBP7.4m mainly due to higher adjusted EBITDA year on year,
lower relative investment in working capital and lower interest
paid following the debt restructuring noted above.
Looking forward
After completing our first year on AIM, we are looking forward
to consolidating the investments in our new production facility in
Leyland and our new distribution centre in Skelmersdale. As before,
our goal is to provide shareholder value through the provision of
quality products and services to our existing and new customers.
The Board has proposed a final dividend of 4p per ordinary share
giving a total of 6p per ordinary share for the full year. The
Board remains committed to a progressive dividend policy.
James Flude
Chief Financial Officer
10 July 2017
Consolidated income statement for the year ended 30 April
2017
Continuing operations Note 2017 2016
GBP'000 GBP'000
Revenue 4 135,053 118,219
- Cost of sales before gain on
derivative financial instruments (97,374) (84,996)
- Gain on derivative financial
instruments - 1,266
------------------------------------- ----- --------- ---------
Cost of sales (97,374) (83,730)
------------------------------------- ----- --------- ---------
Gross profit 37,679 34,489
Administration expenses (15,698) (13,138)
Distribution costs (11,453) (9,431)
Operating profit 5 10,528 11,920
Analysed as:
-----------------------------------
- Adjusted EBITDA(1) 16,061 15,038
- Depreciation 10 (1,910) (1,831)
- Amortisation 11 (2,042) (2,060)
- Gain on derivative financial
instruments - 1,266
- Exceptional items 5 (1,581) (493)
------------------------------------- ----- --------- ---------
Operating profit 10,528 11,920
Finance costs (1,129) (4,941)
Analysed as:
----------------------------------- ----- --------- ---------
- Finance costs on
pre-IPO debt structure 8 (478) (4,456)
- Finance costs on
post-IPO debt structure 8 (651) (485)
------------------------------------- ----- --------- ---------
Finance costs (1,129) (4,941)
------------------------------------- ----- --------- ---------
Profit before tax 9,399 6,979
Tax charge 9 (2,023) (1,274)
------------------------------------- ----- ---------
Profit for the year attributable to
equity shareholders 7,376 5,705
-------------------------------------------- --------- ---------
Consolidated statement of comprehensive income for the year
ended 30 April 2017
2017 2016
GBP'000 GBP'000
Profit for the year attributable
to equity shareholders 7,376 5,705
Other comprehensive (expense) /
income for the year
Revaluation of derivative financial
instruments(2) (2,868) -
Tax relating to components of other
comprehensive income 545 -
Total comprehensive income attributable
to equity shareholders 5,053 5,705
------------------------------------------- -------- --------
Earnings per share
GBP GBP
Basic and Diluted 6 0.09 576.26
Adjusted 25 0.12 680.20
The notes are an integral part of these consolidated financial
statements.
Note 1: Adjusted EBITDA, which is defined as profit before
finance costs, tax, depreciation, amortisation, gain / (loss) on
derivative financial instruments and exceptional items, is a
non-GAAP metric used by management and is not an IFRS
disclosure.
Note 2: Items that could potentially be reclassified
subsequently to profit and loss
Consolidated statement of financial position for the year ended
30 April 2017
2017 2016
Note GBP'000 GBP'000
ASSETS
Non-current assets
Property, plant and
equipment 10 26,914 24,407
Intangible assets 11 29,742 31,744
----------------------------- ----- -------- --------
Total non-current
assets 56,656 56,151
----------------------------- ----- -------- --------
Current assets
Inventories 12 14,358 9,361
Trade and other receivables 13 24,670 21,277
Cash and cash equivalents 14 3,867 2,456
Deferred tax asset 9 545 -
Derivative financial
instruments 17 841 -
----------------------------- ----- -------- --------
Total current assets 44,281 33,094
----------------------------- ----- -------- --------
Total assets 100,937 89,245
----------------------------- ----- -------- --------
Non-current liabilities
Borrowings 16 13,146 50,919
Deferred tax liabilities 9 4,336 4,478
Derivative financial
instruments 17 474 -
Total non-current
liabilities 17,956 55,397
----------------------------- ----- -------- --------
Current liabilities
Borrowings 16 9,709 12,193
Trade and other payables 15 18,840 15,454
Income taxes payable 920 909
Derivative financial
instruments 17 3,235 190
Total current liabilities 32,704 28,746
----------------------------- ----- -------- --------
Total liabilities 50,660 84,143
----------------------------- ----- -------- --------
Net assets 50,277 5,102
----------------------------- ----- -------- --------
Capital and reserves
Share capital 20 93 13
Share premium 41,597 84
Hedging reserve (2,323) -
Capital redemption
reserve 27 -
Retained earnings 10,883 5,005
Total equity shareholders'
funds 50,277 5,102
------------------------------------ -------- --------
The financial statements were approved by the Board of Directors
on 10 July 2017.
Signed on behalf of the Board of Directors
Steve Crossley James Flude
Chief Executive Officer Chief Financial Officer
Company Registration Number 09019496
Consolidated statement of changes in equity for the year ended
30 April 2017
Note Share Share Hedging Capital (Accumulated Total
capital Premium reserve redemption losses) equity
reserve / retained
earnings
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1 May
2015 10 50 - - (700) (640)
Transactions with
owners
Issue of ordinary
shares 3 34 - - - 37
--------------------------- ----- --------- --------- --------- ------------ ------------- ------------
Total for transactions
with owners 3 34 - - - 37
--------------------------- ----- --------- --------- --------- ------------ ------------- ------------
Comprehensive income
Profit for the
year - - - - 5,705 5,705
Total comprehensive
income - - - - 5,705 5,705
--------------------------- ----- --------- --------- --------- ------------ ------------- ------------
Balance at 30 April
2016 and at 1 May
2016 13 84 - - 5,005 5,102
Comprehensive income
/ (expense)
Profit for the
year - - - - 7,376 7,376
Revaluation of
derivative financial
instruments - - (2,868) - - (2,868)
Tax relating to
components of other
comprehensive income - - 545 - - 545
Total comprehensive
income - - (2,323) - 7,376 5,053
--------------------------- ----- --------- --------- --------- ------------ ------------- ------------
Transactions with
owners recognised
directly in equity
Bonus issue of
shares 20 64 (64) - - - -
Proceeds from shares
issued 20 43 43,285 - - - 43,328
Buy back of deferred
shares for consideration
of GBP1 20 (27) - - 27 - -
Transaction costs - (1,708) - - 166 (1,542)
Dividends - - - - (1,860) (1,860)
Share based payments - - - - 196 196
Total transactions
recognised directly
in equity 80 41,513 - 27 (1,498) 40,122
--------------------------- ----- --------- --------- --------- ------------ ------------- ------------
Balance at 30 April
2017 93 41,597 (2,323) 27 10,883 50,277
--------------------------- ----- --------- --------- --------- ------------ ------------- ------------
Consolidated cash flow statement for the year ended 30 April
2017
Notes 2017 2016
GBP'000 GBP'000
Cash flows from operating
activities
Operating profit 10,528 11,920
Adjustment for:
Depreciation 5,10 1,910 1,831
Amortisation 5,11 2,042 2,060
(Gain) on derivative
financial instruments - (1,266)
Grant income (212) (61)
Exceptional items 1,016 -
Share based payments 196 -
Profit on disposal of
property, plant and
equipment (26) (22)
----------------------------------- ------ --------- --------
Operating cash flows before
movements in working capital 15,454 14,462
(Increase) / decrease
in inventories (4,997) 20
Increase in trade and
other receivables (3,224) (1,975)
Increase / (decrease)
in trade and other payables 6,431 (1,433)
----------------------------------- ------ --------- --------
Cash generated from
operations 13,664 11,074
Tax paid (2,149) (1,460)
Interest paid (4,131) (4,918)
----------------------------------- ------ --------- --------
Net cash flows from
operating activities 7,384 4,696
----------------------------------- ------ --------- --------
Cash flows from investing
activities
Purchase of property,
plant and equipment (4,417) (683)
Proceeds from sale of property,
plant and equipment 56 48
---------------------------------- ------ --------- --------
Net cash flows used
in investing activities (4,361) (635)
----------------------------------- ------ --------- --------
Cash flows from financing
activities
Proceeds of issue of
ordinary shares 43,328 37
Cost of raising finance (1,971) -
Increase in amounts
due to factors 2,038 1,656
Repayment of capital
element of finance leases (10,737) (3,082)
Repayment of bank loans (3,900) (1,200)
Receipt of new bank 12,730 -
loans
Repayment of shareholder (41,240) -
loans / loan notes
Drawdown of shareholder
loans / loan notes - 249
Dividend paid to ordinary (1,860) -
shareholders
--------------------------------- ------ --------- --------
Net cash flows (from) financing
activities (1,612) (2,340)
---------------------------------- ------ --------- --------
Net increase in cash
and cash equivalents 1,411 1,721
Cash and cash equivalents
at beginning of the year 14 2,456 735
---------------------------------- ------ --------- --------
Cash and cash equivalents
at year end 14 3,867 2,456
----------------------------------- ------ --------- --------
Notes to the consolidated financial information
1. General information
Accrol Group Holdings plc (formerly Accrol Group Holdings
Limited), (the "Company") was incorporated in England 30 April 2014
with company number 09019496. It is a public company limited by
shares and it is domiciled in England in the United Kingdom. The
registered address of the Company is the Delta Building, Roman
Road, Blackburn, Lancashire, BB1 2LD.
The Company's subsidiaries are listed in note 22, which together
with the Company form the Accrol Group Holdings plc Group (the
"Group").
2. Summary of significant accounting policies
A summary of the significant accounting policies is set out
below. These have been applied consistently in the financial
statements.
Basis of preparation
The consolidated financial statements of the Group have been
prepared in accordance with International Financial Reporting
Standards ('IFRS') as adopted for use in the EU, IFRS
Interpretation Committee ('IFR IC') interpretations and with those
parts of the Companies Act 2006 applicable to companies reporting
under IFRS.
The consolidated financial statements have been prepared on a
going concern basis under the historical cost convention, as
modified by financial liabilities (including derivative
instruments) at fair value through profit or loss. The consolidated
financial statements are presented in pounds sterling and all
values are rounded to the nearest thousand pounds, except where
otherwise indicated.
Standards issued not yet effective
At the date of authorisation of this financial information, the
following new standards, amendments and interpretations which have
not been applied in this financial information were in issue but
not yet effective (and in some cases, had not yet been adopted by
the EU):
-- IAS 16 and IAS 38 amendments - Clarification of Acceptable
Methods of Depreciation and Amortisation (effective 1 January
2016)
-- IFRS 11 amendments - Accounting for Acquisitions of Interests
in Joint Operations (effective 1 January 2016)
-- IAS 16 and IAS 41 amendments - Agriculture: Bearer Plants (effective 1 January 2016)
-- IAS 27 amendments - Equity Method in Separate Financial
Statements (effective 1 January 2016)
-- IFRS 10 and IAS 28 amendments - Sale or Contribution of
Assets between an Investor and its Associate or Joint Venture
(effective 1 January 2016)
-- IAS 1 amendments - Disclosure Initiative (effective 1 January 2016)
-- Annual Improvements 2012-2014 Cycle (effective 1 January 2016)
-- IFRS 15 - Revenue from Contracts with Customers (effective 1 January 2018)
-- IFRS 9 Financial Instruments (effective 1 January 2018)
The adoption of these Standards and Interpretations is not
expected to have a material impact on the consolidated financial
statements of the Group in the year of initial application when the
relevant standards come into effect.
IFRS 16 'Leases' is a new standard that has been published and
is effective from 1 January 2019 but has not been early adopted by
the Group and could have a material impact on the Group financial
information. At the time of preparing this financial information,
the Group continues to assess the possible impact of the adoption
of this standard in future years.
Going Concern
The Directors have made appropriate enquiries and formed a
judgement at the time of approving the financial information that
there is a reasonable expectation that the Group has adequate
resources to continue in operational existence for the foreseeable
future. For this reason, the Directors continue to adopt the going
concern basis in preparing the financial information.
Consolidation
Subsidiaries
A subsidiary is an entity controlled, either directly or
indirectly, by the Company. Control is achieved when the Group is
exposed, or has rights, to variable returns from its involvement
with the investee and has the ability to affect those returns
through its power over the investee. Specifically, the Group
controls an investee if and only if the Group has:
-- power over the investee (i.e. existing rights that give it
the current ability to direct the relevant activities of the
investee);
-- exposure, or rights, to variable returns from its involvement
with the investee; and
-- the ability to use its power over the investee to affect its
returns.
When the Group has less than a majority of the voting or similar
rights of an investee, the Group considers all relevant facts and
circumstances in assessing whether it has power over an investee,
including:
-- the contractual arrangement with the other vote holders of
the investee;
-- rights arising from other contractual arrangements; and
-- the Group's voting rights and potential voting rights.
The Group re-assesses whether or not it controls an investee if
facts and circumstances indicate that there are changes to one or
more of the three elements of control. Consolidation of a
subsidiary begins when the Group obtains control over the
subsidiary and ceases when the Group loses control of the
subsidiary. Assets, liabilities, income and expenses of a
subsidiary acquired or disposed of during the year are included in
the statement of comprehensive income from the date the Group gains
control until the date the Group ceases to control the
subsidiary.
When necessary, adjustments are made to the financial
information of subsidiaries to bring their accounting policies into
line with the Group's accounting policies. All intra-group assets
and liabilities, equity, income, expenses and cash flows relating
to transactions between members of the Group are eliminated in full
on consolidation.
Subsidiaries are all entities (including special purpose
entities) over which the Group has the power to govern the
financial and operating policies generally accompanying a
shareholding of more than one half of the voting rights.
Subsidiaries are fully consolidated from the date on which control
is transferred to the Group. They are de-consolidated from the date
that control ceases.
The acquisition method of accounting is used to account for the
acquisition of subsidiaries by the Group. The cost of an
acquisition is measured as the fair value of the assets given,
equity instruments issued and liabilities incurred or assumed at
the date of exchange. Identifiable assets acquired and liabilities
and contingent liabilities assumed in a business combination are
measured initially at their fair values at the acquisition date,
irrespective of the extent of any minority interest. The excess of
the cost of acquisition over the fair value of the Group's share of
the identifiable net assets acquired is recorded as goodwill. If
the cost of acquisition is less than the fair value of the net
assets of the subsidiary acquired, the difference is recognised
directly in the income statement.
Segments
Operating segments are reported in a manner consistent with the
internal reporting provided to the chief operating decision maker.
The chief operating decision maker, who is responsible for
allocating resources and assessing performance of the operating
segment, has been identified as the Board of Directors. The Group's
activities consist solely of the conversion of paper products,
primarily within the United Kingdom. It is managed as one entity
and management have consequently determined that there is only one
operating segment.
Segment results are measured using adjusted earnings before
interest, tax, depreciation, amortisation, gain / (loss) on
derivative financial instruments and exceptional items. Segment
assets are measured at cost less any recognised impairment. Revenue
is attributed to geographical regions based on the country of
residence of the customer. All revenue arises in and all
non-current assets are located in the United Kingdom. The
accounting policies used for segment reporting reflects those used
for the Group.
Revenue
Revenue representing sales to external customers, which is
stated excluding Value Added Tax and trade discounts, is measured
at the fair value of the consideration receivable for goods
supplied.
Revenue from the sale of goods is recognised at the point of
dispatch of goods from the warehouse as this reflects the transfer
of risks and rewards of ownership.
Revenue is presented net of trade spend, including customer
rebates, which consists primarily of customer pricing allowances,
listing fees and promotional allowances (overriders) which are
governed by agreements with our trade customers. Accruals are
recognised under the terms of these agreements, to reflect the
expected promotional activity and our historical experience. These
accruals are reported within trade and other payables.
Cost of sales
Cost of sales comprise costs arising in connection with the
conversion of paper products. Cost is based on the cost of a
purchase on a first in first out basis and includes all direct
costs and an appropriate portion of fixed and variable overheads
where they are directly attributable to bringing the inventories
into their present location and condition.
Exceptional items
Items that are material in size or unusual or infrequent in
nature are included within operating profit and disclosed
separately as exceptional items in the consolidated income
statement.
The separate reporting of exceptional items, which are presented
as exceptional within the relevant category in the consolidated
income statement, helps provide an indication of the Group's
underlying business performance.
EBITDA and Adjusted EBITDA
Earnings before Interest, Taxation, Depreciation and
Amortisation (EBITDA) and Adjusted EBITDA are non-GAAP measures
used by management to assess the operating performance of the
Group. EBITDA is defined as profit before finance costs, tax,
depreciation and amortisation. Depreciation is the write down of
fixed assets and amortisation of the write down of customer
relationships held in intangibles. Exceptional items and gains /
(losses) on derivative financial instruments are excluded from
EBITDA to calculate Adjusted EBITDA.
The Directors primarily use the Adjusted EBITDA measure when
making decisions about the Group's activities. As these are
non-GAAP measures, EBITDA and Adjusted EBITDA measures used by
other entities may not be calculated in the same way and hence are
not directly comparable.
Foreign currency
Functional and presentation currency
Items included in the financial information are measured using
the currency of the primary economic environment in which the Group
operates ('the functional currency'). The financial information is
presented in Sterling, which is the functional currency of all
companies in the Group.
Transactions and balances
Transactions in foreign currencies are initially recorded in the
functional currency by applying the spot exchange rate ruling at
the date of the transaction. Monetary assets and liabilities
denominated in foreign currencies are retranslated at the
functional currency rate of exchange ruling at the statement of
financial position date. All differences are taken to the income
statement.
Non-monetary items that are measured in terms of historical cost
in a foreign currency are translated using the exchange rates as at
the dates of the initial transactions. Non-monetary items measured
at fair value in a foreign currency are translated using the
exchange rates at the date when the fair value was determined.
Property, plant and equipment
Property, plant and equipment are included at cost less
accumulated depreciation and any recognised impairment loss.
Depreciation is calculated to write down the cost of the assets
on a straight-line or reducing balance basis over the estimated
useful lives on the following bases:
-- Leasehold land and Buildings straight line over term of lease
-- Plant and Machinery 10% straight line, 40% residual value
-- Motor vehicles 30% straight line
-- Fixtures, fittings and office equipment 25% reducing balance
Assets under construction are not depreciated, but transferred
into the appropriate asset class when they are ready for use. The
estimated useful lives are reviewed at the end of each reporting
period and adjusted if appropriate. The carrying values of tangible
fixed assets are reviewed for impairment if events or changes in
circumstances indicate the carrying value may not be
recoverable.
Intangible assets
Goodwill
Goodwill represents the excess of the cost of an acquisition
over the fair value of the group's share of the net identifiable
assets of the acquired subsidiary at the date of acquisition.
Goodwill on acquisitions of subsidiaries is included in 'intangible
assets'. Goodwill is tested annually for impairment and carried at
cost less accumulated impairment losses. Impairment
losses on goodwill are not reversed. Gains and losses on the
disposal of an entity include the carrying amount of goodwill
relating to the entity sold.
Customer relationships, customer order books and other
Customer relationships are shown at fair value as part of
acquisition accounting. Customer relationships have finite useful
lives and are carried at cost less accumulated amortisation.
Amortisation is calculated using the straight-line method to
allocate the cost of customer relationships over their estimated
useful lives 10 years.
Customer order books relate to order for goods awaiting dispatch
at the date of acquisition on 14 July 2014. Amortisation is
calculated using the straight-line method to allocate the cost of
customer order books over their estimated useful lives up to 1
year.
The other intangible asset relates to a Management Services
Agreement between Accrol Papers Limited and Accrol Group Holdings
Plc (formerly Accrol Group Holdings Limited). This agreement has an
infinite life and therefore is not amortised.
Impairment of non-financial assets
Goodwill is tested for impairment annually and when
circumstances indicate that the carrying value may be impaired.
Assets that are subject to depreciation and amortisation are
reviewed for impairment whenever events or changes in circumstances
indicate that the carrying amount may not be recoverable. An
impairment loss is recognised for the amount by which the asset's
carrying amount exceeds its recoverable amount. The recoverable
amount is the higher of an asset's fair value less costs to sell
and value in use. Where the asset does not generate cash flows that
are independent from other assets, the Group estimates the
recoverable amount of the cash-generating unit ("CGU") to which the
asset belongs. All tangibles and intangibles are allocated to the
Group's sole CGU (see note 11).
Any impairment charge is recognised in the income statement in
the period in which it occurs. Impairment losses relating to
goodwill cannot be reversed in future periods. Where an impairment
loss on other assets, subsequently
reverses due to a change in the original estimate, the carrying
amount of the asset is increased to the revised estimate of its
recoverable amount.
Financial instruments
Financial Assets
The Group classifies its financial assets as loans and
receivables. Loans and receivables are non-derivative financial
assets with fixed or determinable payments that are not quoted in
an active market. They are included in current assets, except for
maturities greater than 12 months after the end of the reporting
date, which are classified as non-current assets. The Group's loans
and receivables comprise 'trade and other receivables' and cash and
cash equivalents in the balance sheet. Subsequent to initial
recognition, these assets are carried at amortised cost using the
effective interest method. Income from these financial assets is
calculated on an effective yield basis and is recognised in the
income statement.
Financial liabilities
The Group initially recognises its financial liabilities at fair
value net of transaction costs where applicable and subsequently
they are measured at amortised cost using the effective interest
method. Transaction costs are amortised using the effective
interest rate method over the maturity of the loan.
Derivative financial instruments and cash flow hedges
The Group holds derivative financial instruments to hedge its
foreign currency exposures. These derivatives, classified as cash
flow hedges, are initially recognised at fair value and then re
measured at fair value at the end of each reporting date. Hedging
instruments are documented at inception and effectiveness is tested
throughout their duration. Changes in the value of cash flow hedges
are recognised in other comprehensive income and any ineffective
portion is immediately recognised in the statement of comprehensive
income. Amounts deferred in other comprehensive income are
recognised in the statement of comprehensive income in the same
period in which the hedged items affects profit.
All derivative financial instruments are initially measured at
fair value on the contract date and are also measured at fair value
at subsequent reporting dates.
Share based payments
The Group may issue equity settled share-based payments in the
parent company to certain employees in exchange for services
rendered. These awards are measured at fair value on the date of
the grant using an option pricing model and expensed in the
statement of comprehensive income on a straight line basis over the
vesting period after making an allowance for the number of shares
that it is estimated will not vest. The level of vesting is
reviewed and adjusted annually.
Leases
Finance leases
Assets funded through finance leases are capitalised as
property, plant and equipment, and are depreciated over their
estimated useful lives or the lease term, whichever is shorter. The
amount capitalised is the lower of the fair value of the asset or
the present value of the minimum lease payments during the lease
term at the inception of the lease. The resulting lease obligations
are included in liabilities net of finance charges. Finance costs
on finance leases are charged directly in the income statement on
an effective interest rate basis.
Material lease arrangements do not include any contingent rental
conditions, options to purchase or escalation clauses. There are no
restrictions imposed by these lease arrangements.
Operating leases
Leases in which a significant portion of the risks and rewards
of ownership are retained by the lessor are classified as operating
leases. Payments made under operating leases (net of any incentives
received from the lessor) are charged to the income statement on a
straight-line basis over the period of the lease.
Government grants
Government grants relating to tangible fixed assets are treated
as deferred income and released to the income statement over the
expected useful lives of the assets concerned. Other grants are
credited to the profit and loss account as the related expenditure
is incurred.
Inventories
Inventories are valued at the lower of cost and net realisable
value. Cost is based on the purchase on a first in first out basis
and includes all direct costs and an appropriate portion of fixed
and variable overheads. Net realisable value is the estimated
selling price reduced by all costs of completion, marketing,
selling and distribution. Supplier rebates are credited to the
carrying value of inventory to which they relate. Once the
inventory is sold, the rebate amount is then recognised in the
income statement.
Trade and other receivables
Trade and other receivables relate mainly to the sale of paper
products to trade customers.
Cash and cash equivalents (excluding bank overdraft)
Cash and cash equivalents in the balance sheet comprise cash at
bank, short-term deposits held at call with banks and other
short-term highly liquid investments with original maturities of
three months or less, excluding any bank overdrafts which are
disclosed separately within borrowings within current
liabilities.
Trade payables
Trade payables are obligations to pay for goods or services that
have been acquired in the ordinary course of business from
suppliers. Accounts payable are classified as current liabilities
if payment is due within one year or less. If not, they are
presented as non-current liabilities.
Current taxation
Current tax assets and liabilities for the current and prior
periods are measured at the amount expected to be recovered from or
paid to the taxation authorities. The tax rates and tax laws used
to compute the amount are those that are enacted or substantively
enacted by the balance sheet date.
Income tax relating to items recognised in comprehensive income
or directly in equity is recognised in comprehensive income or
equity and not in the income statement.
Deferred taxation
Deferred income tax is provided using the liability method on
all temporary differences at the balance sheet date between the tax
bases of assets and liabilities and their carrying amounts for
financial reporting purposes, with the following exceptions:
-- where the temporary difference arises from the initial
recognition of goodwill or of an asset or liability in a
transaction that is not a business combination that at the time of
the transaction affects neither accounting nor taxable profit or
loss;
-- in respect of taxable temporary differences associated with
investments in subsidiaries, where the timing of the reversal of
the temporary differences can be controlled and it is probable that
the temporary differences will not reverse in the foreseeable
future; and
-- deferred income tax assets are recognised only to the extent
that it is probable that taxable profit will be available against
which deductible temporary differences, carried forward tax credits
or tax losses can be utilised.
The carrying amount of deferred income tax assets is reviewed at
each balance sheet date and reduced to the extent that it is no
longer probable that sufficient taxable profit will be available to
allow all or part of the deferred income tax asset to be
utilised.
The amount of deferred tax provided is based on the expected
manner of realisation or settlement of the carrying amount of
assets and liabilities. Deferred income tax assets and liabilities
are measured at the tax rates that are expected to apply to the
period when the asset is realised or the liability is settled,
based on tax rates and tax laws that have been enacted or
substantively enacted at the balance sheet date.
Provisions
Provisions are recognised when the Group has a present legal or
constructive obligation as a result of a past event; it is probable
that an outflow of resources will be required to settle the
obligation; and a reliable estimate can be made of the amount of
the obligation.
Provisions are measured at the present value of the expenditures
expected to be required to settle the obligation using a pre-tax
rate that reflects current market assessments of the time value of
money and risks specific to the obligation. The increase in the
provision due to the passage of time is recognised as interest
expense.
3. Significant accounting judgements, estimates and
assumptions
The preparation of the financial information in accordance with
IFRS requires estimates and assumptions to be made that affect the
value at which certain assets and liabilities are held at the
balance sheet date and also the amounts of revenue and expenditure
recorded in the year. The Directors believe the accounting policies
chosen are appropriate to the circumstances and that the estimates,
judgements and assumptions involved in its financial reporting are
reasonable.
Accounting estimates made by the Group's management are based on
information available to management at the time each estimate is
made. Accordingly, actual outcomes may differ materially from
current expectations under different assumptions and
conditions.
The estimates and assumptions for which there is a significant
risk of a material adjustment to the financial information within
the next financial year are set out below.
Critical accounting estimates and judgements in applying the
entity's accounting policies
Goodwill and intangible asset impairment
The Group is required to test, on an annual basis, whether
goodwill has suffered any impairment based on the recoverable
amount of its sole CGU. The recoverable amount is determined based
on value in use calculations. The use of this method requires the
estimation of future cash flows and the determination of a pre-tax
discount rate in order to calculate the present value of the cash
flows. More information including carrying values is included in
note 11.
Customer rebates
The Group provides for amounts payable to customers in relation
to rebates and promotional activity. Whilst the Directors do not
consider the Group's rebates to be highly complex as they are
predominantly volume related, there is judgement required in
calculating amounts due, as terms vary by customer.
Accounting for IPO
The successful completion of the IPO has resulted in a
significant change in the Group's financing structure, both in
terms of equity and debt and has had a significant impact upon the
Group financial statements. Accounting for the IPO and in
particular for the transaction fees incurred requires an element of
judgement as costs determined to be directly related to the IPO are
deducted from the share premium account. Non directly related are
expensed as incurred.
4. Revenue
The analysis of geographical area of destination of the Group's
revenue is set out below:
2017 2016
GBP'000 GBP'000
United Kingdom 132,184 118,041
Europe 2,869 178
------------------- -------- --------
Total 135,053 118,219
------------------- -------- --------
Major customers
In 2017 there were four major customers that individually
accounted for at least 10% of total revenues (2016: four
customers). The revenues relating to these customers in 2017
were GBP31,597,000, GBP14,532,000, GBP13,981,000,
GBP12,602,000 (2016: GBP25,369,000, GBP14,300,000, GBP13,769,000
and GBP12,375,000).
5. Operating profit
Operating profit is stated after charging / (crediting):
2017 2016
GBP'000 GBP'000
Employee benefit
expense 11,857 9,927
Depreciation of property, plant and
equipment (included in administration
expenses) 1,910 1,831
Amortisation of intangible assets
(included in administration expenses) 2,042 2,060
Profit on disposal of property,
plant and equipment (26) (22)
Operating lease
rentals 1,957 1,946
Net foreign exchange losses
/ (gains) 27 (1,332)
Grants income (212) (61)
Auditors' remuneration 311 59
Inventories recognised
as expenses 75,947 66,807
Exceptional items
Professional fees relating 208 -
to the AIM flotation
Early settlement charges 454 -
on finance leases
Acquisition deal 352 -
fees
Consultancy fees 567 334
Other - 159
-------------------------------------------
1,581 493
---------------------------------------- -------- --------
The exceptional items are described below:
Year ended 30 April 2017
Professional fees of GBP208,000 incurred as part of the IPO
process have been classified as exceptional as they do not directly
relate to the raising of the equity for the AIM flotation so cannot
be charged against share premium. In addition, part of the funds
raised in the IPO were used to reduce the debt in the business with
the majority of the finance leases being repaid which attracted an
early redemption charge of GBP454,000.
Fees totalling GBP352,000 relating to the acquisition of the
Accrol Group in July 2014 by Accrol Group Holdings Limited, were
also required to be written off as part of the accounting for the
IPO.
Consultancy costs totalling GBP567,000 were incurred as part of
the restructuring. These related mainly to the Hussain Family
consultancy, manufacturing consultancy and human resourcing
consultancy.
Year ended 30 April 2016
One off consultancy fees totalling GBP334,000 were incurred in
relation to a market, competitor, customer and working capital
review to support the growth strategy following the acquisition in
July 2014.
In September 2015, there was a fire within the embossing unit of
one of the converting lines. The line was back up and running
within one week with no disruption to customer orders. The cost of
repair was GBP159,000.
Auditors' remuneration
2017 2016
GBP'000 GBP'000
Audit services
- Company 13 7
Audit services
- Rest of group 53 29
Non audit services:
Tax compliance
services 11 10
Tax advisory
services 9 13
Advice upon
IPO 225 -
311 59
---- ---- ---- ------------ --------
6. Earnings per share
The basic earnings per share is calculated by dividing the
profit attributable to ordinary equity holders of the parent by the
weighted average number of ordinary shares outstanding during the
year. Diluted earnings per share is calculated by dividing the
profit after tax by the weighted average number of shares in issue
during the year, adjusted for potentially dilutive share options.
The following reflects the income and share data used in the
earnings per share calculations:
2017 2016
GBP'000 GBP'000
Profit for the year attributable
to shareholders 7,376 5,705
Number Number
Basic weighted average
number of shares (1) 85,113,194 9,900
Dilutive share options 1,321,025 -
Diluted weighted average 86,434,219 -
number of shares
GBP GBP
Basic earnings per share 0.09 576.26
Diluted earnings per
share 0.09 576.26
Note 1: In the year ended 30 April 2016 and 2017, the basic
weighted average number of shares was calculated by excluding the D
class of shares (see note 20) as this class is subject to a
dividend cap that does not materially impact upon the profit due to
the remaining Ordinary equity shareholders.
The share option scheme in operation post flotation is dependent
upon share price movements and could therefore result in future
dilution of earnings per share.
7. Employee costs
2017 2016
GBP'000 GBP'000
Employee costs during the
year amounted to:
Wages and salaries 10,748 9,171
Social security costs 801 684
Other pension costs 112 72
Cost of employee share schemes 196 -
(Note 23)
----------------------------------- -------- --------
11,857 9,927
----------------------------------- -------- --------
The average number of employees (including the
executive directors) during the year were:
Number Number
Production 462 431
Administration 46 29
------------------------------------ -------- --------
508 460
----------------------------------- -------- --------
8. Finance costs
2017 2016
GBP'000 GBP'000
Finance costs on pre-IPO
debt structure
Shareholder loans 478 4,099
Finance lease interest - 214
Amortisation of finance
fees - 143
----------------------------- -------- --------
478 4,456
Finance costs on post-IPO
debt structure
Bank loans and overdrafts 368 158
Finance lease interest 80 144
Interest on factoring
facility 160 183
Amortisation of finance 43 -
fees
----------------------------- -------- --------
651 485
Total finance costs 1,129 4,941
----------------------------- -------- --------
9. Income tax expense
Tax charged in the income 2017 2016
statement
GBP'000 GBP'000
Current income tax
Current tax on profits
for the year 2,165 1,780
------------------------------ -------- --------
Total current income
tax 2,165 1,780
------------------------------ -------- --------
Deferred tax
Origination and reversal
of temporary differences (163) (31)
Change in tax rate 21 (475)
------------------------------ -------- --------
Total deferred tax (142) (506)
------------------------------ -------- --------
Tax charge in the income
statement 2,023 1,274
------------------------------ -------- --------
The tax charge for the year is higher (2016: lower) than the
effective rate of Corporation Tax in the UK of 19.92% (2016: 20%).
The differences are explained below:
2017 2016
GBP'000 GBP'000
Profit before income
tax 9,399 6,979
Effective rate 19.92% 20%
At the effective income
tax rate 1,872 1,396
Expenses not deductible
for tax purposes 130 353
Change in rate 21 (475)
---------------------------- -------- --------
Total tax charge 2,023 1,274
---------------------------- -------- --------
During the year the Group recognised the following deferred tax
(assets) / liabilities:
Accelerated Derivative
capital financial
allowances Intangibles instruments Other Total
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
30 April 2015 1,576 3,734 - (326) 4,984
Credit / (charge)
in year 127 (412) - 254 (31)
Change in deferred
tax rate (176) (306) - 7 (475)
30 April 2016 1,527 3,016 - (65) 4,478
-------------------- ------------ ------------ ------------- -------- --------
Credit / (charge)
in year 186 (414) - 65 (163)
Change in deferred
tax rate (18) 39 - - 21
Credit to equity - - (545) - (545)
-------------------- ------------ ------------ ------------- -------- --------
30 April 2017 1,695 2,641 (545) - 3,791
-------------------- ------------ ------------ ------------- -------- --------
The following is the analysis of deferred tax balances for
financial reporting purposes:
2017 2016
GBP'000 GBP'000
Deferred tax assets (545) -
Deferred tax liabilities 4,336 4,478
-------- --------
3,791 4,478
-------------------------- -------- --------
The deferred tax asset was recognized on the loss on cash flow
hedges and the credit has been taken to the hedging reserve.
Deferred tax expected to be settled within 12 months of the
reporting date is approximately GBP58,000 (2016: GBP186,000).
The Finance Act 2016 reduced the main rate of corporation tax to
20% from 1 April 2016 and to 19% from 1 April 2017. A future rate
reduction to 18% from 1 April 2020, was substantively enacted on 26
October 2015. A further change to reduce the rate from 1 April 2020
from 18% to 17% was announced on 16 March 2016. This change was
substantively enacted as part of the Finance Bill 2016 on 15
September 2016. Therefore, the rate of 20% (2016: 20%) has been
reflected in the consolidated financial statements and deferred tax
assets and liabilities have been measured at the rate expected to
be in effect when the deferred tax asset or liability reverses.
Deferred tax has been provided at the rate of 18% as at 30 April
2017 (2016: 18%).
10. Property, plant and equipment
Leasehold Fixtures Plant Motor Assets Total
land & fittings and vehicles under
& buildings machinery construction
Cost GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
At 30 April
2015 156 532 19,013 133 4,417 24,251
Transfer - - 4,417 - (4,417) -
Additions - 173 162 37 3,152 3,524
Disposals - - (49) (35) - (84)
---------------- ------------- ------------ ----------- ---------- -------------- --------
At 30 April
2016 156 705 23,543 135 3,152 27,691
Additions - 344 684 46 3,373 4,447
Disposals - - - (138) - (138)
---------------- ------------- ------------ ----------- ---------- -------------- --------
At 30 April
2017 156 1,049 24,227 43 6,525 32,000
---------------- ------------- ------------ ----------- ---------- -------------- --------
Accumulated
depreciation
At 30 April
2015 39 86 1,335 51 - 1,511
Charge 10 119 1,626 76 - 1,831
Disposals - - (23) (35) - (58)
---------------- ------------- ------------ ----------- ---------- -------------- --------
At 30 April
2016 49 205 2,938 92 - 3,284
Charge 10 140 1,739 21 - 1,910
Disposals - - (18) (90) - (108)
---------------- ------------- ------------ ----------- ---------- -------------- --------
At 30 April
2017 59 345 4,659 23 - 5,086
---------------- ------------- ------------ ----------- ---------- -------------- --------
Net book value
At 30 April
2017 97 704 19,568 20 6,525 26,914
---------------- ------------- ------------ ----------- ---------- -------------- --------
At 30 April
2016 107 500 20,605 43 3,152 24,407
---------------- ------------- ------------ ----------- ---------- -------------- --------
The net book value of tangible fixed assets includes an amount
of GBP538,000 (2016: GBP16,052,000) in respect of plant and
machinery assets held under finance leases and GBPnil (2016:
GBP3,152,000) in respect of assets under construction held under
finance leases.
11. Intangible assets
Goodwill Customer Order Other Total
lists book
Cost GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
30 April 2015 14,982 20,427 86 - 35,495
Additions - - - - -
---------------- ---------- --------- -------------- -------------- ----------------------------
At 30 April
2016 14,982 20,427 86 - 35,495
Additions - - - 40 40
----------------- ---------- --------- -------------- -------------- ----------------------------
At 30 April
2017 14,982 20,427 86 40 35,535
----------------- ---------- --------- -------------- -------------- ----------------------------
Amortisation
30 April 2015 - 1,623 68 - 1,691
Charge - 2,042 18 - 2,060
----------------- ---------- --------- -------------- -------------- ----------------------------
At 30 April
2016 - 3,665 86 - 3,751
Charge - 2,042 - - 2,042
----------------- ---------- --------- -------------- -------------- ----------------------------
At 30 April
2017 - 5,707 86 - 5,793
----------------- ---------- --------- -------------- -------------- ----------------------------
Net book value
At 30 April
2017 14,982 14,720 - 40 29,742
----------------- ---------- --------- -------------- -------------- ----------------------------
At 30 April
2016 14,982 16,762 - - 31,744
----------------- ---------- --------- -------------- -------------- ----------------------------
The balance for Goodwill, Customer relationships and Order book
arose on the Group's Acquisition of Accrol Holdings Limited and are
attributed to the sole cash-generating unit ('CGU').
The intangible addition during the year, relates to a Management
Services Agreement between Accrol Papers Limited and Accrol Group
Holdings Plc which provides a mechanism for a recharge of salary
costs between the two entities.
Impairment test for goodwill
Goodwill is monitored for internal management purposes at the
Group's sole CGU level. The recoverable amount of the CGU has been
determined based on a value in use calculation using cash flow
projections based on financial budgets approved by the board
covering a five year period. Cash flows beyond this period are
extrapolated using the estimated growth rates stated in the key
assumptions.
The key assumptions used in the value in use calculations are a
pre-tax discount rate of 13% (2016: 16%) and a long term growth
rate of 2% (2016: 2%). The discount rate is derived from the
Group's weighted average cost of capital and is calculated with
reference to latest market assumptions for the risk free rate,
equity market risk premium and the cost of debt. The values reflect
both past experience and external sources of information.
Goodwill is tested for impairment on at least an annual basis,
or more frequently if events or changes in circumstance indicate
that the carrying value may be impaired. In the years under review
management's value in use calculations have indicated no
requirement to impair.
Sensitivity to changes in assumptions
The estimates of the recoverable amounts associated with these
CGU affords significant head room over the carrying value,
consequently only significant adverse changes in these key
assumptions would cause the group to recognize an impairment
loss.
12. Inventories
2017 2016
GBP'000 GBP'000
Raw materials 9,090 6,996
Finished goods and
goods for resale 5,268 2,365
---------------------- -------- --------
14,358 9,361
-------------------- -------- --------
There are GBPnil provisions held against inventories (2016:
GBPnil).
13. Trade and other receivables
2017 2016
GBP'000 GBP'000
Trade receivables 23,751 20,793
Less: provision for impairment
of trade receivables (85) (85)
--------------------------------- -------- --------
Trade receivables
- net of provisions 23,666 20,708
Prepayments 1,004 569
---------------------------------- -------- --------
24,670 21,277
-------------------------------- -------- --------
The trade receivables balance is aged as follows:
2017 2016
GBP'000 GBP'000
Less than 1 month 14,048 12,831
Between 1 and 2 months 8,267 7,120
Between 2 and 3 months 988 383
Between 3 and 6 months 448 459
-------------------------- -------- --------
23,751 20,793
------------------------ -------- --------
Trade and other receivables which are less than three months
past due are not considered impaired unless specific information
indicates otherwise. Trade and other receivables greater than three
months past due are considered for recoverability, and where
appropriate, a provision against bad debt is recognised. There are
no trade receivables amounts more than six months past due.
Included in the Group's trade receivables balance are debtors
which are past due at the reporting date for which the Group has
not provided as there has not been a significant change in the
credit quality and the amounts are considered recoverable.
The directors consider that the carrying amount of trade and
other receivables is approximately equal to their fair value.
The movement in the provision for trade and other receivables is
analysed below:
2017 2016
GBP'000 GBP'000
At the beginning
of the year (85) (62)
Provisions made for
receivables impairment - (23)
(85) (85)
------------------------- -------- --------
The creation and release of the provision for impaired
receivables has been included in administrative expenses in the
Income Statement. Amounts charged to the allowance account are
generally written off when there is no expectation of recovering
additional cash.
14. Cash and cash equivalents
2017 2016
GBP'000 GBP'000
Cash and cash equivalents 3,867 2,456
----------------------------- -------- --------
Cash and cash equivalents earn interest at floating rates based
on daily bank deposit rates. Short-term deposits are made for
varying periods of between one day and one month depending on the
immediate cash requirements of the Group, and earn interest at the
respective short-term deposit rates.
15. Trade and other payables
2017 2016
GBP'000 GBP'000
Trade payables 14,892 7,868
Social security and other
taxes 1,558 1,947
Accruals and deferred income 1,576 4,613
Deferred government grant
income 814 1,026
-------------------------------- -------- --------
18,840 15,454
------------------------------ -------- --------
Trade payables are non-interest bearing and are paid on average
within 30 days at 30 April 2017 (2016: 29 days).
Deferred government grant income relates to grants received for
purchase of plant and machinery.
16. Borrowings
2017 2016
GBP'000 GBP'000
Non-current
Bank facility 12,778 2,600
Finance leases 368 7,232
Shareholder loans - 41,087
-------- --------
13,146 50,919
---------------------------- -------- --------
Current
Bank facility - 1,103
Factoring facility 9,523 7,485
Finance leases 186 3,605
------------------------------ -------- --------
9,709 12,193
---------------------------- -------- --------
Loan maturity analysis:
Within one year 9,709 12,294
Between one and two years 185 4,164
Between two and five years 13,183 5,768
After five years - 41,240
------------------------------ -------- --------
23,077 63,466
---------------------------- -------- --------
The following amounts
remain undrawn and available 2017 2016
GBP'000 GBP'000
Revolving credit facility 3,000 -
Factoring facility 13,043 9,879
16,043 9,879
---- ------------ --------
The Group's bank borrowings are secured by way of fixed and
floating charge over the Group's assets.
HSBC Revolving Credit Facility agreement ("Bank facility")
At 30 April 2016, the Group had borrowings under a committed
bank loan facility of GBP4 million provided by HSBC plc, a
factoring facility of GBP20 million and finance leases of GBP8
million. Subsequent to the year end, on 13 June 2016, the bank loan
facility and the finance leases have been repaid from a new
Revolving Credit Facility ("RCF"). The RCF is a 5 year GBP18
million facility with a day 1 drawdown of GBP13 million. The RCF
reduces to GBP10 million subject to the following profile
30 April 2017: GBP16 million
30 April 2018: GBP14 million
30 April 2019: GBP12 million
30 April 2020: GBP10 million
The minimum drawing is: GBP500,000 with the maximum number of outstanding drawings at any
one time being 10. Interest is charged on the RCF at LIBOR plus a margin of 2.0% subject to
the below ratchet:
>=2.0x Net Debt: EBITDA = 2.25 basis points
>=1.5x Net Debt: EBITDA = 2.00 basis points
>=1.0x Net Debt: EBITDA = 1.75 basis points
<1.0x Net Debt: EBITDA = 1.50 basis points
An arrangement fee of 1.5% of the RCF is payable at inception.
An annual commitment fee of 40% of applicable margin on any undrawn
RCF commitment is also payable. There is no commitment fee or
ticking fee arising between signing and Admission. The facility is
subject to financial covenants and each of Accrol Group Holdings
plc (formerly Accrol Group Holdings Limited), Accrol UK Limited,
Accrol Holdings Limited and Accrol Papers Limited will enter into a
guarantee and the security each have previously granted in favour
of HSBC shall remain in respect of all liabilities arising under
the RCF agreement.
HSBC GBP20 million factoring credit facility ("Factoring
facility")
On 8 August 2014 the Group entered into a GBP20.0 million
multi-currency revolving credit facility to provide factoring
financing for general working capital requirements for a minimum
period of 3 years. Under the terms of this facility the drawdown is
based upon gross debtors less a retention with 90% of the remaining
debt funded. Each drawing under the facility is repayable within a
maximum of 90 days from date of invoice for jurisdictions within
the United Kingdom and 120 days for other countries.
Covenants
The Group is subject to financial covenants in relation to the
Bank Facility and the Factoring facility. The covenants in relation
to the Bank Facility cover the following ratios: a) Interest cover
and b) Leverage. The covenants in relation to the Factoring
Facility cover the following: a) Debt dilution, c) Disputed debt
and d) Tangible net worth. The Group has been in compliance with
all of the covenants during the year under review. Breach of the
covenants would render any outstanding borrowings subject to
immediate settlement.
Finance fees
Finance fees are not included in the Loan Maturity Analysis
table. As at 30 April 2017, finance fees relating to the
arrangement of the Revolving Credit Facility have been capitalised
and are being amortised. As at the 30 April 2016, the finance fees
were incurred upon the arrangement of the shareholder loans by the
Group's lenders.
The finance fees after amortisation are as follows:
2017 2016
GBP'000 GBP'000
Finance fees 222 354
---------------- ------------------ --------
17. Financial instruments
Derivative financial instruments
Derivative financial instruments represent the Group's forward
foreign exchange contracts. The liabilities representing the
valuations of the forward foreign exchange contracts at the
year-end are:
2017 2016
Foreign currency contracts GBP'000 GBP'000
Current assets 841 -
Current liabilities (3,235) (190)
Non-current liabilities (474) -
---------------------------- ------------------ --------
(2,868) (190)
---------------------------- ------------------ --------
The fair value of a derivative financial instrument is split
between current and non-current depending on the remaining maturity
of the derivative contract and its contractual cash flows. The
foreign currency swaps are designated as fair value through profit
or loss at initial recognition. The fair value of the Group's
foreign currency derivatives is calculated as the difference
between the contract rates and the mark to market rates which are
current at the balance sheet date. This valuation is obtained from
the counterparty bank and at each year end is categorised as a
Level 2 valuation, see below. The maximum exposure to credit risk
is the fair value of the derivative as a financial asset.
Fair value hierarchy
IFRS 7 requires fair value measurements to be recognised using a
fair value hierarchy that reflects the significance of the inputs
used in the value measurements:
Level 1: inputs are quoted prices in active markets.
Level 2: a valuation that uses observable inputs for the asset
or liability other than quoted prices in active markets.
Level 3: a valuation using unobservable inputs i.e. a valuation
technique.
There were no transfers between levels throughout the years
under review.
Fair values
The fair values of the Group's financial instruments
approximates closely with their carrying values, which are set out
in the table below:
Fair values and
Carrying values
-------------------------- ---- -------------------
2017 2016
Financial assets GBP'000 GBP'000
Current
Trade receivables 23,666 20,708
Cash and short-term
deposits 3,867 2,456
Derivative financial 841 -
instruments
-------------------------- --- --------- --------
Financial liabilities
Current
Borrowings 9,709 12,193
Trade and other payables 18,840 15,454
Derivative financial
instruments 3,235 190
-------------------------------- --------- --------
Non-Current
Borrowings 13,146 50,919
Derivative financial 474 -
instruments
-------------------------------- --------- --------
18. Capital and financial risk management objectives and
policies
(a) Capital risk management
The Group's objective when managing capital is to safeguard the
group's ability to continue as a going concern in order to provide
returns for shareholders and benefits for other stakeholders and to
maintain an optimal capital structure to reduce the cost of
capital. In order to maintain or adjust capital the group may
adjust the amount of dividends paid to shareholders, return capital
to shareholders, issue new shares or sell assets to reduce
debt.
Consistent with others in the industry, the group monitors net
debt. Net debt is calculated as total borrowings less cash and cash
equivalents.
2017 2016
GBP'000 GBP'000
Total borrowings 22,855 63,112
Less: cash and cash equivalents (3,867) (2,456)
----------------------------------- -------- --------
Net debt 18,988 60,656
----------------------------------- -------- --------
(b) Financial risk management
The Group has exposure to the following risks from its use of
financial instruments:
-- Foreign currency risk
-- Interest rate risk
-- Liquidity risk
-- Credit risk
This note presents information about the Group's exposure to
each of the above risks, and the Group's objectives, policies and
procedures for measuring and managing risk. The Board of Directors
has overall responsibility for the establishment and oversight of
the Group's risk management framework.
(i) Foreign currency risk
The Group has transactional currency exposures arising from
purchases in currencies other than the Group's functional currency.
These exposures are forecast on a monthly basis and are monitored
by the Finance Department. Under the Group's foreign currency
policy, such exposures are hedged on a reducing percentage basis
over a number
of forecast time horizons using forward foreign currency
contracts.
The Group's largest exposures are the US Dollar and Euro forward
contracts. The derivative analysis below had been prepared by
reperforming the calculations used to determine the balance sheet
values assuming a 1% strengthening of Sterling:
2017 2016
GBP'000 GBP'000
Euro - (loss) (79) -
USD - (loss) / gain (844) 135
------------------------ -------- --------
(923) 135
--------------------- -------- --------
(ii) Interest rate risk
Interest rate risk is the risk that the fair value or future
cash flows of a financial instrument will fluctuate because of
changes in market interest rates. The Group's exposure to the risk
of changes in market interest rates relates primarily to the
Group's Factoring facility and Bank facility, both of which have
floating interest rates.
The Group manages its interest rate risk by holding the majority
of borrowings in fixed rate secured loan notes. The exposure to the
remaining risk is deemed to be manageable and is reviewed on a
continual basis. The Group are not expecting any reduction in
interest rates over the next 12 months, the impact of 0.5% increase
in interest rates on profit before tax is shown below:
2017 2016
GBP'000 GBP'000
Change in interest
rate 94 56
----------------------- -------- --------
(iii) Liquidity risk
Liquidity risk is the risk that the Group will not be able to
meet its financial obligations as they fall due. Ultimate
responsibility for liquidity risk management rests with the Board
of Directors. The Group manages liquidity risk by continuously
monitoring forecast and actual cash flows, matching the maturity
profiles of financial assets and operational liabilities and by
maintaining adequate cash reserves.
The table below summaries the maturity profile of the Group's
financial liabilities:
As at 30 April 2017
Due Due Due Due in Total
within between between more
1 year 1 and 2 and than
2 years 5 years 5 years
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Borrowings 9,709 185 13,183 - 23,077
Trade and other payables 18,840 - - - 18,840
Derivative financial
instruments 3,235 474 - - 3,709
----------------------------- -------- --------- --------- --------- --------
Total financial liabilities 31,784 659 13,183 - 45,626
----------------------------- -------- --------- --------- --------- --------
As at 30 April 2016
Due Due Due Due in
within between between more Total
1 year 1 and 2 and than
2 years 5 years 5 years
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Borrowings 12,295 4,163 5,768 41,240 63,466
Trade and other payables 15,454 - - - 15,454
Derivative financial
instruments 190 - - - 190
----------------------------- -------- --------- --------- --------- --------
Total financial liabilities 27,939 4,163 5,768 41,240 79,110
----------------------------- -------- --------- --------- --------- --------
(iv) Credit risk
The Group's principal financial assets are bank balances and
cash, trade and other receivables and investments. The group's
credit risk is low. The credit risk on liquid funds and derivative
financial instruments is limited because the counterparties are
banks with high credit ratings assigned by international
credit-rating agencies.
19. Commitments and contingencies
Operating lease commitments
The Group has entered into leases on commercial real estate.
These leases have an average life of 9 years with no renewal option
included in the contracts. There are no restrictions placed upon
the Group by entering into these leases. The lease expenditure
charged to the income statement during the year is disclosed in
note 5.
Future minimum rentals payable under non-cancelable operating
leases as at the year end, analysed by the period in which they
fall due, are as follows:
2017 2016
GBP'000 GBP'000
Within 1 year 2,821 1,740
Between 1 and 2
years 3,614 1,740
Between 2 and 5
years 10,879 5,220
Greater than 5 years 17,191 6,516
-------- --------
34,505 15,216
---------------------- -------- --------
Finance lease commitments
Future minimum lease payments under finance leases and hire
purchase contracts together with the present value of the net
minimum lease payments are, as follows:
2017 2016
GBP'000 GBP'000
Within 1 year 198 3,989
Between 1 and 2 years 192 3,228
Between 2 and 5 years 190 4,617
-------------------------- -------- --------
580 11,834
Future finance charges (29) (997)
-------------------------- -------- --------
Present value 551 10,837
-------------------------- -------- --------
The present value of finance lease liabilities is as
follows:
2017 2016
GBP'000 GBP'000
Within 1 year 184 3,605
Between 1 and 2 years 184 2,963
Between 2 and 5 years 183 4,269
--------
551 10,837
----------------------- -------- --------
Capital commitments
2017 2016
GBP'000 GBP'000
Contracted for but
not provided - -
------------------- -------- --------
20. Share capital and reserves
Called up, allotted and fully 2017 2016
paid GBP GBP
Ordinary shares of GBP0.001 93,012
each -
Class A Ordinary shares of GBP1
each - 4,625
Class B Ordinary shares of GBP1
each - 4,625
Class C Ordinary shares of GBP1
each - 650
Class D Ordinary shares of GBP1
each - 2,860
--------------------------------- ------- -------
93,012 12,760
----------------------------------------- -------
The number of ordinary shares in issue is set out below:
2017 2016
Number Number
Ordinary shares of GBP0.001 93,012,002 -
each
Class A Ordinary shares of GBP1
each - 4,625
Class B Ordinary shares of GBP1
each - 4,625
Class C Ordinary shares of GBP1
each - 650
Class D Ordinary shares of GBP1
each - 2,860
The movements in shares occurred on the following dates set out
below:
Number
31 May 2016
Issue of A Ordinary shares
of GBP1 each 50
Issue of B Ordinary shares
of GBP1 each 50
1 June 2016
Bonus issue of shares 5:1
Bonus issue of A Ordinary
shares of GBP1 each 23,375
Bonus issue of B Ordinary
shares of GBP1 each 23,375
Bonus issue of C Ordinary
shares of GBP1 each 3,250
Bonus issue of D Ordinary
shares of GBP1 each 14,300
Subdivision of shares
Subdivided A ordinary shares
of GBP0.001 each 28,050,000
Subdivided B ordinary shares
of GBP0.001 each 28,050,000
Subdivided C ordinary shares
of GBP0.001 each 3,900,000
Subdivided D ordinary shares
of GBP0.001 each 17,160,000
Re-organisation of shares
into one class
Ordinary shares of one class
of GBP0.001 each 49,683,858
Deferred shares of one class
of GBP0.001 each 27,476,142
10 June 2016
Issue of Ordinary shares
of GBP0.001 each 43,328,144
11 July 2016
Purchase of Deferred shares
of GBP0.001 each 27,476,142
On 1 June 2016, a 5:1 bonus issue of shares occurred and
subsequent to this, all shares were subdivided into shares of
GBP0.001 each. On the same day, all shares were re-organised into
one class of share and then were reassigned to either Ordinary or
Deferred class.
On 10 June 2016, further ordinary shares of GBP0.001 were
issued.
On 11 July 2016, all deferred shares were purchased by Accrol
Group Holdings plc (formerly Accrol Group Holdings Limited) for
GBP1.
Each holder of the GBP0.001 Ordinary Shares are entitled to vote
at general meetings of the Company. Every holder of an Ordinary
Share shall have one vote for each Ordinary Share held.
21. Dividends
2017 2016
GBP'000 GBP'000
Amounts recognised as distributions
to the owners of the parent in the
year:
Interim dividend for the year ended
30 April 2017 of 2 pence (2016: GBPnil)
per share 1,860 -
Total distributions to the owners of
the parent in the year 1,860 -
----------------------------------------- -------- --------
Proposed final dividend for the year
ended 30 April 2017 of 4 pence (2016:
GBPnil) per share 3,720 -
----------------------------------------- -------- --------
The proposed final dividend is subject to approval of the
shareholders at the AGM and has not been included as a liability in
these financial statements. It will be recognised in the
shareholders' equity in the year ending 30 April 2018.
22. Related party disclosures
(a) Identity of related parties
The Company's significant shareholders include NorthEdge Capital
LP and members of the Hussain family. Phoenix Court Blackburn
Limited is a company under the control of the Hussain family
providing commercial premises for letting. Alklar Limited is an
entity under the common directorship of Peter Cheung, to which
payments for Peter Cheung's services as a director for Accrol UK
Limited were made. Post the AIM listing, Peter Cheung is now
remunerated for his services via payroll. Nisiac Limited is a
company under the control of the Hussain family, to which payments
for the consulting services of the Hussain family were made.
The subsidiaries of the Group are as follows:
Company Principal Country Holding
activity of incorporation %
------------------------- ----------------- ------------------- --------
Holding United
Accrol UK Limited company Kingdom 100%
Holding United
Accrol Holdings Limited company Kingdom 100%
United
Accrol Papers Limited Paper convertor Kingdom 100%
The registered address of all subsidiaries in the Group is the
Delta Building, Roman Road, Blackburn, Lancashire, BB1 2LD.
(b) Transactions with related parties
The following table provides the total amounts owed to / (due
from) related parties as at the end of each year:
2017 2016
GBP'000 GBP'000
NorthEdge Capital LP - 21,704
NorthEdge Capital -
GP - 460
The Hussain family - 22,126
Alklar Limited - 270
Nisiac Limited - -
Owed to related parties - 44,560
--------------------------- --------- --------
Opening balance 44,560 44,262
Loans advanced during
year - 249
Interest charged 478 4,099
Purchases 2,003 1,898
Repayments (47,041) (5,948)
Owed to related parties - 44,560
--------------------------- --------- --------
Borrowings - 41,240
Trade & other payables - 3,320
--------------------------- --------- --------
Owed to related parties - 44,560
--------------------------- --------- --------
Note 16 details loan notes net of financing fees.
The following table provides the total amounts of purchases and
interest charged from related parties for the relevant financial
year:
Transactions
2017 2016
GBP'000 GBP'000
NorthEdge Capital LP 259 2,129
The Hussain family 241 2,050
Phoenix Court Blackburn
Limited 1,744 1,740
Alklar Limited 62 78
Nisiac Limited 175 -
------------------------- -------- --------
Total 2,481 5,997
--------------------------- -------- --------
Terms and conditions of transactions with related parties
The purchases and loans from related parties are made at normal
market prices. Outstanding balances at the year-end are unsecured,
interest free and settlement occurs in cash. There have been no
guarantees provided for any related party payables. Loans from
related parties in comparative periods carried interest at 10%.
Payments to Phoenix Court Blackburn Limited are in respect of the
provision of services. Payments to Nisiac Limited are in respect of
the provision of consultancy services.
(c) Directors' emoluments
2017 2016
GBP'000 GBP'000
Directors' fees 62 72
Salaries 649 709
Share based payments 196 -
Post employment
benefit 32 -
939 781
---------------------- -------- --------
During the year retirement benefits were accruing to nil
directors under defined contribution schemes (2016: nil). The
aggregate amount of emoluments paid to the highest paid director
was GBP305,000 (2016: GBP204,000).
(d) Key management personnel
Key management personnel are considered to be the executive and
non-executive directors of the Company. The remuneration of all
directors who have been identified as the key management personnel
of the group is set out above in aggregate for each of the
categories specified in IAS 24 Related Party Disclosures:
(e) Company transactions with its subsidiaries
The Company received dividends from and charged management fees
to its' subsidiaries in the current year as summarised in the table
below:
2017 2016
GBP'000 GBP'000
Dividends received 10,000 -
Management fees
charged 620 -
10,620 -
------------------- -------- --------
23. Share based payments
The charge for share based payments under IFRS 2 arises under
the Management Incentive Plan ("MIP"). The total expense recognised
for the year arising from share-based payment was GBP196,503 (2016:
GBPnil). All of the total share based payments expense arises from
transactions accounted for as equity-settled share-based payment
transactions.
Movements in the number of share options outstanding and their
relative weighted average exercise prices are as follows:
2017 2017 2016 2016
Average exercise Average exercise
price in GBP price in GBP
per share Options per share Options
option (Number) option (Number)
At 1
May - -
Granted 1.30 3,052 - -
Forfeited - - - -
Exercised - - - -
Expired - - - -
At 30
April 1.30 3,052 - -
===================================== ========== ================= ==========
Out of the 3,052 outstanding options (2016:nil) nil options
(2016: nil) were exercisable. No options were exercised in 2017
(2016: nil).
Share options outstanding at the end of the year have the
following expiry date and exercise prices:
Share options
Exercise
price in
Grant Expiry GBP per
- vest date share option 2017 2016
2016-2019 10-Jun-23 1.30 3,052 0
3,052 0
======== ======
The weighted average fair value of options granted during the
period determined using the Black-Scholes-Merton model valuation
was GBP217.5. The significant inputs into the model were the
underlying equity value (taken to be the total market
capitalisation of Accrol Group Holdings plc on admission), the
exercise price of an option (shown above), volatility of 26.95%,
divided yield of 6%.
The volatility is based on statistical analysis of the
volatility of comparable companies over a 5 year period as the
historical data is not available due to Accrol Group Holdings plc's
recent listing on AIM.
See note 7 for the total expense recognised in the income
statement for share options granted to directors and employees.
24. Events after the balance sheet date
Details of the proposed final dividend are given in note 21.
There are no other significant events that have occurred after the
balance sheet date.
25. Alternative performance measures
The Group makes use a number of alternative performance measures
to assess business performance and provide additional useful
information to shareholders about the underlying performance of of
the Group
Adjusted earnings per share
The adjusted earnings per share is calculated by dividing the
adjusted earnings attributable to ordinary equity holder of the
parent by the weighted average number of ordinary shares
outstanding during the year. The following reflects the income and
share data used in the adjusted earnings per share calculation.
2017 2016
GBP'000 GBP'000
Earnings attributable
to shareholders 7,376 5,705
Adjustment for:
Amortisation 2,042 2,060
Gain on derivatives - (1,266)
Exceptional items 1,581 493
Tax effect of adjustments
above (524) (258)
---------------------------------------- ----------- --------
Adjusted earnings attributable
to shareholders 10,475 6,734
---------------------------------------- ----------- --------
Number Number
Basic weighted average
number of shares(1) 85,113,194 9,900
Dilutive share options 1,321,025 -
Diluted weighted average 86,434,219 -
number of shares
GBP GBP
Basic adjusted earnings
per share 0.12 680.20
Diluted adjusted earnings
per share 0.12 680.20
Note 1: In the year ended 30 April 2016 and 2017, the basic
weighted average number of shares was calculated by excluding the D
class of shares as this class is subject to a dividend cap that
does not materially impact upon the profit due to the remaining
Ordinary equity shareholders.
Reconciliation from GAAP- defined reporting measures to the
Group's alternative performance measures
Management use these measurements to better understand the
underlying business of the Group.
Consolidated income statement
2017 2016
(a) Adjusted gross margin GBP'000 GBP'000
Revenue 135,053 118,219
Gross profit 37,679 34,489
Gross margin 27.9% 29.2%
Revenue 135,053 118,219
Gross profit 37,679 34,489
Less: gain on derivative
financial instruments 0 (1,266)
-------- --------
Adjusted gross
profit 37,679 33,223
Adjusted gross
margin 27.9% 28.1%
(b) Adjusted EBITDA
Operating profit 10,528 11,920
Adjusted for:
Depreciation 1,910 1,831
Amortisation 2,042 2,060
Gain on derivative
financial instruments 0 (1,266)
Exceptional
items 1,581 493
Adjusted EBITDA 16,061 15,038
-------- --------
(c) Adjusted PBT
and adjusted PAT
Profit before tax 9,399 6,979
Adjusted for:
Amortisation 2,042 2,060
Gain on derivative
financial instruments 0 (1,266)
Exceptional
items 1,581 493
Adjusted PBT 13,022 8,266
-------- --------
Taxation (2,023) (1,274)
-------- --------
Adjusted PAT 10,999 6,992
-------- --------
Company statement of financial position as at 30 April 2017
2017 2016
Note GBP'000 GBP'000
ASSETS
Non-current assets
Investments in
subsidiaries 5 41,437 10
--------------------------- ----- -------- --------
Total non-current
assets 41,437 10
--------------------------- ----- -------- --------
Current assets
Trade and other
receivables 6 7,904 25
Cash and cash equivalents 287 262
--------------------------- ----- -------- --------
Total current assets 8,191 287
--------------------------- ----- -------- --------
Total assets 49,628 297
--------------------------- ----- -------- --------
Current liabilities
Trade and other
payables 7 - 200
Total current liabilities - 200
--------------------------- ----- -------- --------
Total liabilities - 200
--------------------------- ----- -------- --------
Net assets 49,628 97
--------------------------- ----- -------- --------
Capital and reserves
Share capital 8 93 13
Share premium 41,597 84
Capital redemption
reserve 27 -
Retained earnings
- opening - -
Profit for the
year 7,911 -
--------------------------- ----- -------- --------
Total equity 49,628 97
--------------------------- ----- -------- --------
The financial statements were approved by the Board of Directors
on 10 July 2017.
Signed on behalf of the Board of Directors
Steve Crossley James Flude
Chief Executive Officer Chief Financial Officer
Company Registration Number 09019496
Company statement of changes in equity for the year ended 30
April 2017
Capital
Share Share redemption Retained Total
Note capital Premium reserve earnings equity
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Balance at 1 May
2015 10 50 - - 60
-------------------------- ----- --------- --------- ------------ ---------- --------
Transactions with
owners
Issue of ordinary
shares 8 3 34 - - 37
-------------------------- ----- --------- --------- ------------ ---------- --------
Total for transactions
with owners 3 34 - - 37
-------------------------- ----- --------- --------- ------------ ---------- --------
Comprehensive income
Result for the year - - - - -
Total comprehensive - - - - -
income
-------------------------- ----- --------- --------- ------------ ---------- --------
Balance at 30 April
2016 and at 1 May
2016 13 84 - - 97
-------------------------- ----- --------- --------- ------------ ---------- --------
Transactions with
owners
Bonus issue of ordinary
shares 8 64 (64) - - -
Proceeds from shares
issued 43 43,285 - - 43,328
Buy back of deferred
share for consideration
of GBP1 (27) - 27 - -
Transaction costs - (1,708) - - (1,708)
Dividends - - - (1,860) (1,860)
-------------------------- ----- --------- --------- ------------ ---------- --------
Total for transactions
with owners 80 41,513 27 (1,860) 39,760
-------------------------- ----- --------- --------- ------------ ---------- --------
Comprehensive income
Profit for the year - - - 9,771 9,771
Total comprehensive
income - - - 9,771 9,771
-------------------------- ----- --------- --------- ------------ ---------- --------
Balance at 30 April
2017 93 41,597 27 7,911 49,628
-------------------------- ----- --------- --------- ------------ ---------- --------
Company Cash Flow Statement
2017 2016
GBP'000 GBP'000
Cash flows from operating
activities
Operating profit 9,771 -
Adjustment for:
Exceptional items 3 193 -
-------------------------------------- -------- --------
Operating cash flows before
movement in working capital 9,964 -
(Increase) / decrease in
trade and other receivables (7,879) 25
(Decrease) / increase in
trade and other payables (200) 200
-------------------------------------- -------- --------
Cash generated from operations 1,885 225
-------------------------------------- -------- --------
Net cash flows from operating
activities 1,885 225
------------------------------------------ -------- --------
Cash flows from financing
activities
Proceeds of issue of ordinary
shares - 37
Dividends paid to ordinary
shareholders (1,860) -
-------------------------------------- -------- --------
Net cash flows (used in)
/ from financing activities (1,860) 37
-------------------------------------- -------- --------
Net increase in cash and
cash equivalents 25 262
Cash and cash equivalents at beginning
of the year 262 -
------------------------------------------ -------- --------
Cash and cash equivalents
at year end 287 262
-------------------------------------- -------- --------
1. General information
Accrol Group Holdings plc (formerly Accrol Group Holdings
Limited), (the "Company") was incorporated in England 30 April 2014
with company number 09019496. It is a public company limited by
shares and it is domiciled in the United Kingdom. The registered
address of the Company is the Delta Building, Roman Road,
Blackburn, Lancashire, BB1 2LD The Company's subsidiaries are
listed in note 22 to the consolidated financial statements, which
together with the Company form the Accrol Group Holdings plc Group
(the "Group"). The Company acts as a holding company for the
remainder of the Accrol Group.
2. Summary of significant accounting policies
A summary of the significant accounting policies is set out
below. These have been applied consistently during the financial
year.
Basis of preparation
The financial statements of the Company have been prepared in
accordance with International Financial Reporting Standards
('IFRS') as adopted for use in the EU, International Financial
Reporting Interpretations Committee ('IFRIC') interpretations and
with those parts of the Companies Act 2006 applicable to companies
reporting under IFRS.
The financial statements have been prepared on a going concern
basis under the historical cost convention. The financial
statements are presented in pounds sterling and all values are
rounded to the nearest thousand pounds, except where otherwise
indicated.
The Company has taken advantage of the exemption in Section
408(3) of the Companies Act 2006 not to present its individual
Profit and Loss Account and related notes that form part of the
approved Company financial statements. The retained profit of the
Company is shown in the Statement of Changes in equity.
Standards issued not yet effective
At the date of authorisation of this financial information, the
following new standards and interpretations which have not been
applied in this financial information were in issue but not yet
effective (and in some cases, had not yet been adopted by the
EU):
-- IAS 16 and IAS 38 amendments - Clarification of Acceptable
Methods of Depreciation and Amortisation (effective 1 January
2016)
-- IFRS 11 amendments - Accounting for Acquisitions of Interests
in Joint Operations (effective 1 January 2016)
-- IAS 16 and IAS 41 amendments - Agriculture: Bearer Plants (effective 1 January 2016)
-- IAS 27 amendments - Equity Method in Separate Financial
Statements (effective 1 January 2016)
-- IFRS 10 and IAS 28 amendments - Sale or Contribution of
Assets between an Investor and its Associate or Joint Venture
(effective 1 January 2016)
-- IAS 1 amendments - Disclosure Initiative (effective 1 January 2016)
-- Annual Improvements 2012-2014 Cycle (effective 1 January 2016)
-- IFRS 15 - Revenue from Contracts with Customers (effective 1 January 2018)
-- IFRS 9 Financial Instruments (effective 1 January 2018)
The adoption of these Standards and Interpretations is not
expected to have a material impact on the financial statements of
the Company in the year of initial application when the relevant
standards come into effect.
IFRS 16 'Leases' is a new standard that has been published and
is effective from 1 January 2019 but has not been early adopted by
the Company. It is unlikely to have a material impact on the
Company. At the time of preparing this financial information, the
Company continues to assess the possible impact of the adoption of
this standard in future years.
Going Concern
The Directors have made appropriate enquiries and formed a
judgement at the time of approving the financial statements that
there is a reasonable expectation that the Company has adequate
resources to continue in operational existence for the foreseeable
future. For this reason, the Directors continue to adopt the going
concern basis in preparing the financial statements.
Exceptional items
Items that are material in size or unusual or infrequent in
nature are included within operating profit and disclosed
separately as exceptional items in the consolidated income
statement.
The separate reporting of exceptional items, which are presented
as exceptional within the relevant category in the consolidated
income statement, helps provide an indication of the Group's
underlying business performance.
Investments
On initial recognition, investments in subsidiaries are recorded
at cost, which is the fair value of the consideration paid. Where
consideration is paid by way of shares, the excess of fair value of
the shares over nominal value of those shares is recorded in share
premium. Investments in subsidiaries are reviewed for impairment at
each balance sheet date with any impairment charged to the income
statement.
Financial Instruments
Financial Assets
The Company classifies its financial assets as loans and
receivables. Loans and receivables are non-derivative financial
assets with fixed or determinable payments that are not quoted in
an active market. They are included in current assets. The
Company's loans and receivables comprise debtors and cash and cash
equivalents in the balance sheet. Subsequent to initial
recognition, these assets are carried at amortised cost using the
effective interest method. Income from these financial assets is
calculated on an effective yield basis and is recognised in the
income statement.
Financial liabilities
The company initially recognises its financial liabilities at
fair value and subsequently they are measured at amortised cost
using the effective interest method.
3. Exceptional items
2017 2016
GBP'000 GBP'000
Professional fees relating to the AIM flotation 208 -
208 -
Professional fees of GBP208,000 incurred as part of the IPO
process have been classified as exceptional as they do not directly
relate to the raising of the equity for the AIM flotation.
4. Directors' emoluments
2017 2016
GBP'000 GBP'000
Emoluments 590 -
590 -
----------- -------- --------
Directors' emoluments are recharged by Accrol Papers Limited.
This arrangement has been in place since listing on AIM in June
2016. During the year, management recharges related to three
directors (2016: GBPnil). The Company does not have any employees
(2016: nil).
5. Investments in subsidiaries
Group undertakings
GBP'000
Cost
30 April 2016 10
Additions in the year 41,427
30 April 2017 41,437
On 10 June 2017, the Company subscribed for 2,000 new shares in
Accrol UK Limited for a consideration of GBP41,388,000.
The Company's subsidiary undertakings are shown in note 22 to
the consolidated financial statements.
6. Trade and other receivables
2017 2016
GBP'000 GBP'000
Prepayments and accrued income 10 25
Amounts owed by group undertakings 7,894 -
7,904 25
Amounts owed by group undertakings and falling due within one
year are unsecured, interest free and repayable on demand.
7. Trade and other payables
2017 2016
GBP'000 GBP'000
Amounts owed to group undertakings - 200
- 200
Amounts owed to group undertakings and falling due within one
year are unsecured, interest free and repayable on demand.
8. Issued capital and reserves
Called up, allotted and fully paid
2017 2016
GBP GBP
Ordinary shares of GBP0.001 each 93,012 -
Class A Ordinary shares of GBP1 each - 4,625
Class B Ordinary shares of GBP1 each - 4,625
Class C Ordinary shares of GBP1 each - 650
Class D Ordinary shares of GBP1 each - 2,860
93,012 12,760
The number of ordinary shares in issue is set out below:
Number Number
Ordinary shares of GBP0.001 93,012,002 -
each
Class A Ordinary shares of GBP1
each - 4,625
Class B Ordinary shares of GBP1
each - 4,625
Class C Ordinary shares of GBP1
each - 650
Class D Ordinary shares of GBP1
each - 2,860
The movements in shares occurred on the following dates set out
below:
Number
31 May 2016
Issue of A Ordinary shares
of GBP1 each 50
Issue of B Ordinary shares
of GBP1 each 50
1 June 2016
Bonus issue of shares 5:1
Bonus issue of A Ordinary
shares of GBP1 each 23,375
Bonus issue of B Ordinary
shares of GBP1 each 23,375
Bonus issue of C Ordinary
shares of GBP1 each 3,250
Bonus issue of D Ordinary
shares of GBP1 each 14,300
Subdivision of shares
Subdivided A ordinary shares
of GBP0.001 each 28,050,000
Subdivided B ordinary shares
of GBP0.001 each 28,050,000
Subdivided C ordinary shares
of GBP0.001 each 3,900,000
Subdivided D ordinary shares
of GBP0.001 each 17,160,000
Re-organisation of shares
into one class
Ordinary shares of one class
of GBP0.001 each 49,683,858
Deferred shares of one class
of GBP0.001 each 27,476,142
10 June 2016
Issue of Ordinary shares
of GBP0.001 each 43,328,144
11 July 2016
Purchase of Deferred shares
of GBP0.001 each 27,476,142
On 1 June 2016, a 5:1 bonus issue of shares occurred and
subsequent to this, all shares were subdivided into shares of
GBP0.001 each. On the same day, all shares were re-organised into
one class of share and then were reassigned to either Ordinary or
Deferred class.
On 10 June 2016, further ordinary shares of GBP0.001 were
issued.
On 11 July 2016, all deferred shares were purchased by Accrol
Group Holdings plc (formerly Accrol Group Holdings Limited) for
GBP1.
Each holder of the GBP0.001 Ordinary Shares are entitled to vote
at general meetings of the Company. Every holder of an Ordinary
Share shall have one vote for each Ordinary Share held.
9. Dividend payable
2017 2016
GBP'000 GBP'000
Amounts recognised as distributions
to the owners of the parent in the
year:
Interim dividend for the year ended
30 April 2017 of 2 pence (2016: nil
pence) per share 1,860 -
Total distributions to the owners of
the parent in the year 1,860 -
--------------------------------------- -------- --------
Proposed final dividend for the year
ended 30 April 2017 of 4 pence (2016:
nil pence) per share 3,720 -
--------------------------------------- -------- --------
The proposed final dividend is subject to approval of the
shareholders at the AGM and has not been included as a liability in
these financial statements. It will be recognised in the
shareholders' equity in the year ending 30 April 2018.
10. Dividend receivable
The Company received dividends from its' subsidiaries in the
current year as summarised in the table below:
2017 2016
GBP'000 GBP'000
Dividends received 10,000 -
10,000 -
------------------- -------- --------
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR BLGDRUDGBGRR
(END) Dow Jones Newswires
July 10, 2017 02:00 ET (06:00 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From May 2023 to May 2024